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ABSTRACT 
 
High numbers of US Veterans experience post-traumatic stress disorder (PTSD), 
which may occur in combination with chronic pain and depression, and they may face 
stressful challenges to daily living. Despite the need, many Veterans do not seek care 
following a PTSD diagnosis. In the US, mental health issues fuel over 70% of primary 
care visits, and individuals with PTSD often seek treatment in the primary care setting. 
Integrated mental health (IMH) models of treatment bring mental health professionals 
into the primary care setting, allowing Veterans to receive comprehensive treatment 
during primary care visits. The IMH treatment model may bridge the gap for Veterans 
with PTSD who need care and those who actually receive it. The present study examined 
the impact that IMH has on Veterans with PTSD receiving care from the Veterans Affairs 
(VA) health care system. Using several methods of data collection (e.g., medical chart 
reviews, VA administrative databases, a mailed survey of patient perception of patient-
centered care) the present quasi-experimental evaluation study examined a national 
sample of Veterans with PTSD, to evaluate the impact of IMH treatment (as compared to 
usual mental health care) on: physical health, mental health, PTSD, health services 
utilization, patient perceptions of key patient-centered care constructs, provider 
recommendations for treatment, and considerations of patient preferences for treatment. 
Outcomes were compared for Veterans receiving IMH vs. usual mental health care, to 
assess treatment program impacts; a multivariate logistic regression model was conducted 
x 
to assess variables independently associated with IMH treatment receipt, and; mediation 
analyses examined whether the relationship between IMH treatment and receipt of 
‘adequate’ mental health care is driven by patient perceptions of two important patient-
centered care constructs (patient activation; shared medical decision-making). 
Collectively, the results of this project indicate that, among Veterans with PTSD 
receiving VA health care, IMH treatment receipt is associated with: increased outpatient 
and primary care visits; decreased psychotropic medication use; increased 
recommendations for complementary and alternative medicine (CAM) (e.g., meditation, 
mindfulness and relaxation practices, yoga) treatment modalities; more discussion of 
patient preferences for mental health treatment during more VA primary care and mental 
health encounters; better patient perceptions of physical health status; greater patient 
activation (e.g., engagement in health care), and; better patient perceptions of shared 
medical decision-making. However, no meditational relationships were detected. 
Combining behavioral health care with traditional primary care through an integrative 
mental health treatment model may be most effective in increasing health care 
engagement, shared decision-making, and discussion of patient preferences for mental 
health care among Veterans with PTSD. As such, these treatment efforts may be effective 
in increasing the number of Veterans who receive appropriate, needed health care, as well 
as increasing care-related satisfaction. However, data indicate that some targeted 
improvement efforts geared toward educating providers about the importance of 
discussing and considering patient’s preference for treatment, as well as implementing 
systematic collection of standardized measures of symptom severity for common mental 
health concerns among Veterans receiving VA health care, may be warranted. 
xi 
Collectively, integrating mental health care providers into the primary care setting may 
be a good strategy for encouraging Veterans with PTSD to seek out and stay the course of 
the treatment they need. 
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CHAPTER ONE 
POST-TRAUMATIC STRESS DISORDER: THE HISTORY 
Long before it received an official name and host of diagnostic criteria, 
individuals who experienced or bore witness to traumatic events both experienced and 
discussed what is now known as Post Traumatic Stress Disorder (PTSD) (Trimble, 1985). 
Prior to the conceptualization of PTSD as an official diagnosis, the psychological 
sequelae following exposure to trauma was referred to as various ailments; for instance, 
negative psychological reaction following battles as early as the Russian-Japanese War 
and World War I were documented as having often been referred to as ‘shell shock’, ‘war 
neurosis,’ ‘exhaustion,’ or ‘combat fatigue’ (Mott, 1919; Andreasen, 2004; Croq, 2000) – 
a problem that could be overcome through will-power, ‘manliness’ and a renewed sense 
of duty to one’s country/military (Bogacz, 1989).      
 In 1952, the DSM-I was released and contained the first standardized diagnosis of 
what would become present-day PTSD: Gross Stress Reaction (Andreasen, 2010; 
Andreasen, 2004; American Psychiatric Association (APA), 1952). This disorder, 
however, was not included in the subsequent DSM II (Andreasen, 2010; Andreasen, 
2004), which instead contained a diagnosis called Adjustment Reaction of Adult Life 
(APA, 1968). After decades of returning Vietnam Veterans suffering from what was 
casually referred to as ‘Post-Vietnam Syndrome’, the American Psychiatric Association 
(APA) instituted a task force to place an official name and set of diagnostic criteria to the 
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disorder; as such, PTSD was formally introduced in the DMS-III (Andreasen, 2004; 
APA, 1980). During this time, the diagnostic criteria for PTSD had undergone several 
phases of revisions.  
 The DSM I criteria for a diagnosis of Gross Stress Reaction, albeit brief, specified 
that individuals who did not previously have any previous psychological afflictions may 
suffer from this stress disorder after being subjected to great psychological or physical 
stress (APA, 1952), however, the criteria specified that if the adverse psychological 
reaction lasted longer than a few days to a few weeks, a different diagnosis must be 
determined (Andreasen, 2010). Due to a lengthy period of the US not being involved in 
war, ‘PTSD’ was not included in the DSM II (Andreasen, 2010; Croq, 2000).  However, 
the diagnosis for “Adjustment Reaction of Adult Life” included brief descriptions of what 
are now considered combat-related hypervigilance and hyper-arousal, as well as reactions 
to several other stressors (e.g., car accidents, plane crashes) (APA, 1968).  
 In light of a great number of Vietnam Veterans suffering from psychological 
symptoms for which (collectively) there was no official diagnosis, as well as a plethora of 
published literature reporting symptoms of the psychological ramifications of exposure to 
extreme stressors/trauma (Kral, 1951; Klein, Zellermayer, & Shanan, 1963; Adler, 1943; 
Adler, 1945; Modlin, 1960; Symonds, 1943; Andreasen, 1974; Andreasen, 2010), the 
APA introduced PTSD as an official diagnosis in the DSM III (APA, 1980). The sets of 
diagnostic criteria for PTSD from the DSM III through the DSM IV-TR were relatively 
similar in that they all specified that the afflicted individual must have experienced a 
traumatic event, and clustered symptoms into three groups: re-experiencing, 
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avoidance/numbing, and hyper-arousal.  However, because of the specifications for each 
symptom cluster, what constituted a traumatic stressor became more detailed with each 
version of the DSM (APA, 1980; APA, 1987; APA, 1994,; APA, 2000). Additionally, the 
specification that symptoms must cause “clinically significant distress or impairment in 
social, occupational, or other important areas of functioning” was added to the diagnostic 
criteria in the DSM IV (APA, 1994; APA, 2000).  
 In the early days, suggested treatment for what would now be considered PTSD 
included moving the individual from the front lines to the back of marching combat 
troops to promote psychiatric recovery (Croq, 2000). Shortly thereafter, approaches to 
treatment/attempts at therapeutic interventions evolved to methods such as administration 
of electroconvulsive therapy (Croq, 2000), finding the afflicted individuals gainful 
employment upon their return from the war (Mott, 1919), and providing ‘simple 
treatments’ near the front lines of battle with a clear expectation of the afflicted 
individual returning to combat [referred to as forward treatment]. This ‘forward 
treatment’ method was widely used for cases of PTSD arising during times of combat 
from the WWI era through the Vietnam War (Croq, 2000).  
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CHAPTER TWO 
POST-TRAUMATIC STESS DISORDER: THE PRESENT 
Since PTSD was first introduced as an official diagnosis in 1980, with the release 
of the DSM-III (APA, 1980), the disorder has received an increasing amount of attention 
from the medical community, media, and government officials. In the face of the current 
conflicts in Iraq and Afghanistan, where combat operations are unique both in respect to 
demands on the troops and service members returning home in increasing numbers with 
more severe injuries than in any prior conflict (Tanielian, 2008), the issue of 
appropriately diagnosing and treating PTSD has become increasingly important. 
Diagnostic Criteria 
 With the release of the DSM-V, both the classification and diagnostic criteria for 
PTSD has been revised. Whereas previous versions of the DSM classified PTSD under 
the umbrella category of anxiety disorders (APA, 2000), this diagnosis has now been re-
classified as a Trauma-and-Stress-or-Related Disorder (APA, 2013). Additionally, the 
diagnostic criterion has been expanded from the previous three-factor model of symptom 
clusters (e.g., re-experiencing, avoidance and hyper-arousal; APA, 2000) to a four-factor 
model (e.g., intrusion, avoidance, negative alterations in cognitions/mood, alterations in 
arousal and reactivity; APA, 2013). Further, the diagnostic revision added a specification 
for a dissociative sub-type of the disorder, as well as a sub-type for children (6 years of 
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age or younger), and removed the need for specification of ‘acute’ or ‘chronic’ (APA, 
2013).  
 PTSD is characterized distinctly by its causal factor and first diagnostic criterion 
(criterion A): exposure to a traumatic stressor; the DSM V specifies that the stressor (e.g., 
“death, threatened death, actual or threatened serious injury, or actual or threatened 
sexual violence”) may be experienced directly or indirectly (witnessed, as a function of 
one’s job or through a close friend/family member) (APA, 2013). Further diagnostic 
criteria is as follows: re-experiencing of the trauma; continual avoidance of memory-
inducing stimuli regarding the event; altered affect; consistent and out of character hyper-
arousal or changes in reactivity; and significant distress or impairment in social, 
occupational, or other important areas of functioning (APA, 2013). As opposed to the 
DSM-IV-TR criteria, the DSM-V criteria does not require that “intense fear, helplessness 
or horror happen right after the trauma,” and the criteria no longer classifies the 
unexpected passing of a family member or friend as a traumatic event (APA, 2000; APA, 
2013). 
 The minimum symptom duration to meet diagnostic criteria is one month, 
however, a diagnostic specification of delayed expression is given if the individual is 
diagnosed 6 months or longer after the trauma was experienced, regardless of when (s)he 
began experiencing symptoms (APA, 2013). Further, a diagnostic specification of “with 
dissociative symptoms” (e.g., depersonalization or derealization) may be given (APA, 
2013).  
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Traumatic Stressors (Detailed) 
 A variety of traumatic stressors can lead to the development of PTSD, and there is 
no dichotomous distinction concerning whether an event is or is not traumatizing; rather, 
the capacity for a stressor to be traumatizing exists on a continuum (Wilson, 2004). As 
asserted by Carlson & Dalenberg (2000), in order for an event to act as a traumatic 
stressor it must merely be sudden, negative, and lacking in subjective control for the 
individual. As such, PTSD can develop from a vast array of personal, collective, or 
witnessed experiences.  
 In their 1996 study of a representative sample of Detroit residents, Breslau and 
colleagues (1998) presented a comprehensive assessment of events considered to be 
traumatic stressors, based on diagnostic criteria as defined by the DSM. Their work 
provides a comprehensive overview of potential causes of traumatization, and is 
comprised of the following: “is/was in military combat; raped or other kinds of sexual 
assault; held captive, tortured, or kidnapped; shot or stabbed; mugged, held up,  
threatened with a weapon; badly beaten up; in serious car or motor vehicle crash; 
involved in any other kind of serious accident or injury; fire, flood, earthquake, or other 
natural disaster; diagnosed with a life-threatening illness; one’s child  diagnosed as 
having a life-threatening illness; witnessed someone being killed or seriously injured; 
unexpectedly discovered a dead body; sudden, unexpected death of a close friend or 
relative; learned that a close friend/relative. . . was raped or sexually assaulted; was 
seriously physically attacked; was seriously injured in a motor vehicle crash; or was 
7 
 
seriously injured in any other accident” (Breslau, Kessler, Chilcoat, Schultz, Davis, & 
Andreski, 1998, p. 4). 
 Similarly, but more recently, as part of a series of broad mental health surveys, 
the World Health Organization (WHO) utilized a list of 29 potential traumatic 
experiences. These various types of traumas formed clusters of trauma: being “exposed to 
organized violence” (e.g., being a civilian or relief worker in a combat zone); having 
“participated in organized violence” (e.g., combat); “interpersonal violence” (e.g., having 
been abused as a child, having been mugged); having been a victim of “sexual-
relationship violence” (e.g., having been raped or sexually assaulted); having endured 
“other life-threatening traumatic experiences” (e.g., accidents, natural disasters); and 
having endured “network traumatic experiences” (e.g., unexpected death or trauma of a 
loved one) (Kessler, 2014). 
Military Service 
Despite the wide range of potentially traumatizing events that are not specifically 
related to military membership/service, serving in the military is associated with 
increased risk of having a traumatic experience (Institute of Medicine (IOM), 2008). In 
fact, the United States Department of Veterans Affairs (VA) and Department of Defense 
(DoD) (VA/DoD, 2010) have identified general participation in military operations 
(above and beyond combat in a designated war zone) as an additional service-related 
vehicle of trauma exposure. Traumatic stressors that are specific to participating in 
combat operations include, but are not limited to,: “intense emotional demands; extreme 
fatigue, weather exposure, hunger, sleep deprivation; extended exposure to danger, loss, 
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emotional/physical strain; exposure to environmental hazards, such as toxic 
contamination” (VA/DoD, 2010, pp. 17).  
When an individual experiences a traumatic event, the initial 
psychological/physiological reaction is referred to as an Acute Stress Reaction (ASR) 
(APA, 2000; VA/DoD, 2010). While symptoms of an ASR are reminiscent of PTSD, 
ASRs are often temporary and will not necessarily lead to a diagnosable case of PTSD. If 
symptoms of an ASR last for longer than two days, and are characterized by one 
symptom from each of the (previously three) PTSD symptom clusters (e.g., re-
experiencing, avoidance/numbing, hyper-arousal) and three symptoms of dissociation, a 
diagnosis of Acute Stress Disorder (ASD) is given.  ASD can transition into PTSD if 
symptoms are present for one month or longer following traumatization (APA, 2000; 
VA/DoD, 2010).   
Additionally, individuals serving in combat operations may experience a Combat 
or Operations Stress Reaction (COSR), which is specifically related to the stress of 
military service (in the presence or absence of a distinct trauma) (VA/DoD, 2010). ASD 
symptom onset can occur immediately, or as long as several days following the exposure 
to trauma, and include (but are not limited to) alterations in mood/energy, depression, 
peritraumatic dissociation, substance use, and hyper-arousal.  COSR-specific symptoms 
focus mainly on alteration in [military-related] occupational functioning, such as 
productivity, focus, and motivation (VA/DoD, 2010).  
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Symptom Presentation 
 The presentation of PTSD symptoms is not uniform across the clinical population; 
individuals who meet criteria for a PTSD diagnosis can present with a range of subsets of 
symptom clusters, in varying levels of severity (IOM, 2008; IOM, 2014). As outlined by 
the most recent version of the DSM, there are four main symptom clusters associated 
with PTSD: intrusion, avoidance, negative alterations in cognitions/mood, alterations in 
arousal and reactivity (APA, 2013). PTSD symptom manifestation can be psychological 
and/or physiological in nature (Wilson, 2004). In addition to having experienced a 
traumatic stressor, in order to be given a PTSD diagnosis, an individual must present with 
the following symptoms:  
Intrusion  
The cluster of intrusion symptoms is criterion B for diagnosis in the DSM. Five 
forms of intrusion are presented in the DSM, with the specification that the symptom(s) 
happen “persistently” (APA, 2013). The DSM outlines the following potential symptoms 
under this cluster: intrusion can occur in the form of memories of the event (which must 
be “recurrent, involuntary and intrusive”), dreams about the event (e.g., nightmares/night 
terrors), physiological or psychological reliving of the trauma (e.g., flashbacks), 
maladaptive psychological reactions to stimuli related to the event (e.g., anxiety, terror), 
and maladaptive physiological reactions to stimuli related to the event (e.g., increased 
heart-rate, difficulty breathing) (APA, 2013, p. 467; Wilson, 2004).; An individual must 
present with at least one to meet diagnostic criteria (APA, 2013).  
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Avoidance  
The cluster of avoidance symptoms is criterion C for diagnosis in the DSM. The 
DSM outlines two potential avenues through which avoidance can manifest: 
psychological avoidance of trauma-related stimuli (e.g., “memories, thoughts, or 
feelings”); or, physical avoidance of trauma-related stimuli or stimuli that elicit memories 
of the traumatic event (e.g., “people, places, conversations, activities, objects, or 
situations”) (APA, 2013). An individual must present with at least one to meet diagnostic 
criteria, with the caveat that the individual must not have displayed the behaviors prior to 
being exposed to the traumatic event (APA, 2013).  
Negative Alterations in Cognitions and Mood  
The negative alterations in cognitions and mood symptom cluster is criterion D 
for diagnosis in the DSM.  The DSM outlines seven potential symptoms under the 
negative alterations in cognitions and mood umbrella: amnesia related to the event 
(unrelated to substance use or brain injury); negative, consistent and typically 
unwarranted thoughts or feelings about oneself specifically or society in general; 
consistent and unrelenting self-blame related to the trauma; negative and consistent 
feelings about the trauma, such as shame, guilt or anger; loss of interest in “significant 
activities” that were previously enjoyable; feeling disconnected from others; inhibited 
ability to experience positive emotions (APA, 2013). An individual must present with at 
least two symptoms to meet diagnostic criteria, with the caveat that the symptoms must 
have been non-existent or markedly less intense prior to exposure to the traumatic event 
(APA, 2013).  
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Alterations in Arousal and Reactivity  
The alterations in arousal and reactivity symptom cluster is criterion E for 
diagnosis in the DSM. The DSM outlines five potential symptoms under this cluster. 
Alterations in arousal and reactivity can be experienced through: anger/irritability; 
behavior that would be considered reckless or self-destructive; hypervigilance; increased 
fear-potentiated startle; difficulty concentrating; sleep disturbance (APA, 2013). An 
individual must present with at least two symptoms to meet diagnostic criteria, with the 
caveat that the symptoms must have been non-existent or markedly less intense prior to 
exposure to the traumatic event (APA, 2013).  
Criterion F-H (Duration, Functional Significance & Exclusion)  
In addition to the specific symptom cluster diagnostic requirements, in order for a 
diagnosis of PTSD to be given, the individual must have experienced symptoms for at 
least one month, and these symptoms must have caused a significant impairment in the 
individual’s social or occupational functioning (APA, 2013). Additionally, it must be 
ruled out that symptom presentation is caused by use of controlled or illicit drugs, or 
other psychological illnesses (APA, 2013).  
Epidemiology and Risk/Resilience 
 According to results from the U.S. National Comorbidity Survey-Replication, the 
lifetime prevalence of PTSD in members of the general population in the U.S. is 
approximately 6.8%, with a greater estimated prevalence in women (9.7%) than men 
(3.6%) (Gradus, 2014). Specific to the current conflicts, a survey conducted by the 
RAND Corporation in 2008 reported a PTSD prevalence of 13.8% among individuals 
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who had served in the OEF/OIF combat operations (Gradus, 2014). Other research has 
reported PTSD prevalence rates in individuals having served in the OEF/OIF operations 
to be as low as 10% and as high as 20% (National Center for PTSD, 2009; IOM, 2014). 
Further, PTSD prevalence of 10.1% has been reported among Gulf War Veterans, and 
8.1% - 15.2% (female, male, respectively) of Vietnam Veterans (Gradus, 2014). Not 
every individual exposed to a traumatic stressor develops PTSD. In fact, literature 
suggests that only about one-tenth (Breslau, 2009) to one-third (IOM, 2008) of 
individuals exposed to a traumatic stressor will formally develop the disorder.  
Risk Factors 
 Several risk factors for the development of PTSD, both in general and specific to 
service members and Veterans have been identified in the literature. For instance, having 
an unstable childhood, as well as history of physical or sexual abuse in childhood have 
been tied with the development of combat-related PTSD (Castro, 2014). Being of lower 
socioeconomic status, intelligence, and education, having a history of previous 
trauma/exposure(s) to violence, female gender, having substance abuse problems, 
experiencing peritraumatic dissociation at the time of exposure to a traumatic stressor, the 
severity of the traumatic event (e.g., combat exposure), having poor coping mechanisms, 
having completed a greater number of deployments, undergoing family/life stressors 
during deployment, and being divorced are commonly reported variables that increase 
risk for or are highly associated with the development of PTSD (VA/DoD, 2010; Brewin, 
Andrews, & Valentine, 2000; Shea, Reddy, Tyrka, & Sevin, 2013; Pietrzak, Pullman, 
Cotea, & Peter, 2012; Possemato, McKenzie, McDevitt-Murphy, Williams, & Ouimette, 
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2014; Phillips, LeardMann, Gumbs, & Smith,  2010; Kline et al., 2013; Booth-Kewley, 
Larson, Highfill-McRoy, Garland, & Gaskin, 2010; Hourani et al., 2012; Thomas, Wilk, 
Riviere, McGurk, Castro, & Hoge, 2010; Ozer, Best, Lipsey, & Weiss, 2008; Tolin, & 
Foa, 2006). Additionally, results from the Millennium Cohort Study (a prospective study 
of active duty service members and Veterans that comprises the largest study of this 
nature ever conducted within the US military; Castro, 2014) indicate that combat 
exposure during deployment results in three times the amount of new cases of PTSD 
among service members (vs. those who were not deployed and those who were deployed 
but did not experience combat) (Smith, Ryan, Wingard, Slymen, Sallis, & Kritz-
Silverstein, 2008). Some research has even indicated that there may be a genetic 
predisposition for developing PTSD (American Public Health Association (APHA), 
2013).  
 Factors that come into play after the traumatic event is experienced, such as life 
stressors, including unemployment) and poor social support (along with the trauma 
exposure) can contribute to the likelihood that an individual will develop PTSD 
(VA/DoD, 2010; Polusny, Erbes, Murdoch, Arbisi, Thuras, & Rath, 2011; Brewin et al., 
2000; Pietrzak et al., 2012; Possemato et al., 2014). Additionally, several military 
service-specific factors are associated with the development of PTSD, such as history of 
military sexual trauma while in the service (Castro, 2014) and insufficient deployment 
training (Schultz, Glickman, & Eisen, 2014; Polusny et al., 2011). For cohorts of service 
members who participated in the OEF/OIF operations reported risk factors for the 
development of PTSD include lengthy deployments, higher levels of exposure to combat, 
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traumatic brain injury, decreased unit support, being a reservist/National Guard member, 
and being unmarried (National Center for PTSD, 2011; Polusny et al., 2011; Shen, Arkes, 
Kwan, Tan, & Williams, 2010). Recent research has also ascertained that, even for 
individuals in non-combat roles, being deployed to a combat theatre increases risk for 
post-deployment mental health issues (Peterson, Wong, Haynes, Bush, & Schillerstrom, 
2010), and that severity or chronicity of PTSD may be increased if the traumatic event 
experienced was created by human acts/behaviors (e.g., combat) (APHA, 2013).  
Protective Factors 
Studies have also shown a number of factors that are associated with a decreased 
risk of developing PTSD after exposure to traumatic stressor. For instance, recent 
research conducted with OEF/OIF Veterans suggests that returning service members who 
have greater social support, both among their friends and family and among their unit 
members, are at a decreased risk of developing PTSD (Pietrzak & Southwick, 2011; Han 
et al., 2014; Hourani et al., 2012; Pietrzak, Johnson, Goldstein, & Southwick, 2009). 
Additionally, having served as active duty (vs. National Guard), being in a committed 
relationship (married to or living with a partner), having a higher level of perceived 
control, and having few, if any, problems with psychosocial functioning are associated 
with increased odds of resilience to developing PTSD following combat exposure 
(Pietrzak & Southwick, 2011; Han et al., 2014). Recent literature also suggests that pre-
deployment resiliency training may be effective at increasing psychological resilience 
(Lester, Harms, Herian, Krasikova, & Beal, 2011) and in turn, mitigating the effects of 
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combat-related trauma on individuals’ psyches (Hourani et al., 2011; Pietrzak et al., 
2009).  
PTSD and Health 
Risky Health Behaviors  
Recent literature has also indicated that individuals with PTSD are more likely to 
engage in risky health behaviors, including engaging in physical altercations which may 
lead to physical injury (Widome, Kehle, Carlson, Laska, Gulden, & Lust, 2011), lack of 
exercise (APHA, 2013; Zen, Whooley, Zhao, & Cohen, 2012), tobacco use (APHA, 
2013; Zen et al., 2012), dangerous driving (Sayer, Noorbaloochi, Frazier, Carlson, 
Gravely, & Murdoch, 2010), medication nonadherence (Zen et al., 2012), and misuse of 
alcohol (McDevitt-Murphy, Williams, Bracken, Fields, Monahan, & Murphy, 2010). 
However, the link between PTSD and poor physical health/increased comorbidities 
remains even when such factors are controlled for (Vaccarino et al., 2013). 
Mental Health  
Literature shows that having PTSD is associated with an increased susceptibility 
to having a host of comorbid psychological illnesses and poor health-related quality of 
life (APHA, 2013). Specifically, PTSD is associated with higher frequencies of anxiety 
disorders (e.g., generalized anxiety disorder, panic disorder, phobias, obsessive-
compulsive disorder), depression, bipolar disorder, eating disorders, several personality 
disorders, psychotic disorders (i.e., schizophrenia) (APHA, 2013), and sexual dysfunction 
(Breyer, Cohen, Bertenthal, Rosen, Neylan, & Seal, 2014). Additionally, PTSD is 
associated with substance use disorders, both alcohol and drug-related (APHA, 2013). 
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The association between PTSD and comorbid mental health disorders is especially strong 
in Veterans with a history of military sexual trauma (Maguen, Cohen, Ren, Bosch, 
Kimerling, & Seal, 2012). Recent literature has also shownan association between PTSD 
symptom severity and decreased patient-reported mental health status (Asnaani, Reddy, 
& Shea, 2014). Additionally, individuals with PTSD and comorbid mental health 
conditions tend to experience greater symptom severity and worse outcomes, both in 
terms of health (psychological and physiological) and treatment (APHA, 2013).  
Physical Health  
PTSD has been associated with frequent physiological comorbidities and poor 
health (Pacella, Hruska, & Delahanty, 2013; APHA, 2013; Schnurr, & Green, 2004; 
Wagner, Wolfe, Rotnitsky, Proctor, & Erickson, 2000). Individuals with PTSD suffer in 
high numbers from chronic pain (APHA, 2013; Pacella et al., 2013; Moeller-Bertram, 
Keltner, & Strigo, 2012), obesity and metabolic syndrome (APHA, 2013; Pagoto et al., 
2012; Heppner, Lohr, Kash, Jin, Wang, & Baker, 2012), diabetes (APHA, 2013; 
Agyemang, Goosen, Anujuo, & Ogedegbe, 2012), dementia (APHA, 2013), 
gastrointestinal issues (Pacella et al., 2013; Schnurr, Spiro, & Paris, 2000), 
musculoskeletal disorders (Schnurr et al., 2000), skin disorders (Schnurr et al., 2000), and 
heart-related diseases, including coronary heart disease, hypertension, myocardial 
infarction, hyperlipidemia and cerebrovascular disease (APHA, 2013; Pacella et al., 
2013; Vaccarino et al., 2013; Coughlin, 2011). Additionally, large numbers of individuals 
with PTSD concurrently suffer from traumatic brain injuries (TBI) (APHA, 2013).  
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Treatment 
 According to the Institute of Medicine (2008), a wide range of treatment methods 
are currently practiced for ameliorating the severity of PTSD symptoms. Individuals may 
be treated via medication, therapy, support groups, or even various forms of 
complementary and alternative medicine (CAM) (e.g., meditation, mindfulness and 
relaxation practices, yoga). Treatment modalities may be administered alone, or in 
combination with one another (IOM, 2008).  
Medication  
Seven classes of pharmacological treatments (and a ‘miscellaneous’ group of 
drugs) have been identified in the literature as having been utilized in the treatment of 
PTSD (IOM, 2008). These umbrella categories of medication are as follows: alpha-
adrenergic blockers (e.g., prazosin), anticonvulsants, novel antipsychotics, 
benzodiazepines, monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake 
inhibitors (SSRIs), and other anti-depressants such as tricyclic antidepressants (TCAs), 
noradrenergic and specific serotonergic antidepressants (NaSSAs), and serotonin and 
norepinephrine reuptake inhibitors (SNRIs) (IOM, 2008).    
 According to VA/DoD clinical practice guidelines, however, only SSRIs and 
SNRIs are highlighted as being effective means of treatment for the disorder and 
recommended for front-line use, with TCAs (fair evidence) suggested as an alternative if 
several treatment rounds of SSRIs and SNRIs prove ineffective or cause significant side-
effects (VA/DoD, 2010; VA/DoD, 2013). Additionally, mirtazapine, nefazodone and 
monoamine oxidase inhibitors have been rated as having only fair evidence to support 
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effectiveness in PTSD treatment (VA/DoD, 2013). A number of other medications have 
been rated as ineffective or having insufficient evidence to support recommendation for 
use, and recent VA/DoD clinical practice guidelines specify that benzodiazepines may 
actually be harmful when used as treatment for PTSD (VA/DoD, 2013). 
Therapy  
The majority of therapy methods employed in PTSD treatment use variations of 
cognitive behavioral therapy (CBT) techniques, and include: exposure therapies, eye 
movement desensitization and reprocessing (EMDR), cognitive restructuring, and coping 
skills therapy (IOM, 2008). According to the VA/DoD (2010), these forms of therapy are 
similar in that they all focus specifically on the trauma, and share many elements; for 
example, having the individual face the memories and events related to the trauma, 
determining and altering learned and maladaptive cognitions that are a product of the 
trauma, and teaching relaxation techniques (VA/DoD, 2010).  
 Despite the level of overlap that is present, different methods of therapy treatment 
do possess unique elements. For instance, exposure therapies are centered around the 
individual directly confronting the traumatic event through methods such as in-vivo (i.e., 
a person who is afraid of flying actually boarding an aircraft and flying), imagined, 
written, or orated techniques (VA/DoD, 2010; VA/DoD, 2013). Cognitive restructuring 
therapies, on the other hand, focus more directly on talking through the learned 
cognitions that developed following trauma exposure, and changing those maladaptive 
thoughts to adaptive ones (VA/DoD, 2010; VA/DoD, 2013). Finally, EMDR combines 
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both exposure and cognition-identification elements with training the individual to 
alternate corresponding eye movements (VA/DoD, 2010; VA/DoD, 2013).   
 An additional form of therapy used in the treatment of PTSD, which encompasses 
a bundle of techniques used to combat anxiety, is stress inoculation training (SIT). SIT 
teaches individuals to manage reactions of anxiety and maladaptive stress through 
techniques such as breathing and relaxation training, thought stopping and positive 
thinking (VA/DoD, 2010; VA/DoD, 2013). This treatment bundle entails some CBT 
techniques, relaxation skills focused on breathing and muscles, and elements of exposure 
therapy, as well (VA/DoD, 2013). 
 Exposure, cognitive restructuring and SIT are all strongly recommended and 
identified as being significantly beneficial in the treatment of PTSD by the VA and DoD, 
with other forms of therapy (e.g., group and family therapy, hypnosis) suggested as being 
moderately beneficial but not suited as primary methods of intervention (VA/DoD, 2010; 
VA/DoD, 2013). Recent clinical practice guidelines suggest that front-line treatment 
should begin with a psychotherapeutic approach in tandem with an SSRI or SNRI; 
additionally, prazosin may be added to the treatment regimen at any point to help 
ameliorate sleep difficulties/nightmares (VA/DoD, 2013).   
 The VA requires availability of cognitive processing therapy and prolonged 
exposure therapy for all Veterans who may need them, and offers many other treatment 
options (including CAM treatment modalities) throughout facilities in the VA system of 
care.  Additionally, the VA requires PTSD screening for all Veteran patients at least once 
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a year for the first five years they are receiving care in the VA health care system (IOM, 
2014). 
Complementary and Alternative Treatment Modalities (CAM)  
While VA/DoD clinical practice guidelines rate CAM modalities as not having 
enough evidence to recommend them for front-line treatment, modalities that promote 
relaxation (such as yoga, mindfulness, acupuncture, etc.) are suggested for supplemental 
use to aid in treatment of hyper-arousal symptoms (VA/DoD, 2013). Additionally, these 
guidelines suggest that CAM modalities may be considered for amelioration of comorbid 
conditions such as chronic pain, and may also be useful in individuals who are resistant to 
treatments recommended as front-line options (VA/DoD, 2013).   
Patient Preferences for Treatment 
 As there are multiple treatment options, both front-line recommendations and 
CAM treatment modalities, different patients may prefer to receive a specific treatment or 
treatment regime over the available alternatives. Taking patients’ preferences and values 
into consideration when prescribing a treatment plan is an integral component of 
providing care that is patient-centered (IOM, 2001; Barry, & Edgman-Levitan, 2012). 
When treatment is aligned with patient preferences, patient are more engaged in their care 
(Kwan, Dimidjian, & Rizvi, 2010) and are more likely to be adherent to treatment 
(Thompson, & McCabe, 2012). Further, aligning treatment with patient preferences has 
been associated with improvements in treatment outcomes (Lin et al., 2005) and reduced 
health care costs (Mulley, Trimble, & Elwyn, 2012) and is a goal of the VA (Veterans 
Health Administration (VHA), 2014).  
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 Recent literature has indicated that there may be an association between treatment 
preferences, and both adherence to and effectiveness of treatment in PTSD cohorts 
(Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008). In the VA, engaging patients in 
the decision-making process regarding treatment for PTSD is recommended and 
encouraged.   In fact, a recent study conducted by Mott and colleagues (2014) found that 
an intervention geared toward engaging Veteran patients with PTSD in treatment-
decision making and aligning treatment regiments with patient preferences resulted in 
increased initiation of evidence-based psychotherapy and treatment retention (compared 
with Veterans with PTSD receiving usual care) (Mott, Stanley, Street, Grady, & Teng, 
2014). This study highlights the importance of involving Veterans with PTSD in care-
related decision-making, and taking their preferences into consideration when deciding 
upon and initiating a treatment plan.  
Health Services Utilization 
 Given that having PTSD may decrease immune system function (APHA, 2013) 
and individuals with PTSD tend to suffer from mental and physiological comorbidities 
(APHA, 2013), it is not surprising that use of health services by this population tends to 
be high. Veterans with PTSD have significantly greater health services utilization, above 
and beyond both Veterans without mental health conditions and Veterans with mental 
health conditions other than PTSD (Cohen, Gima, Bertenthal, Kim, Marmar, & Seal, 
2010). Even when controlling for factors that could have an impact on health such as 
smoking status and physical injury related to the trauma, individuals with PTSD are 
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reported to utilize health care services (not including those related to mental health) 
significantly more than non-PTSD cohorts (Buckley, Green, & Schnurr, 2004).  
 Specifically, younger Veterans with a PTSD diagnosis are reported to use 
outpatient health services at the VA more frequently than those without PTSD, and 
increased symptom severity is also related to greater health-care utilization in Veterans 
without documented service-connected disabilities (Calhoun, Bosworth, Grambow, 
Dudley, & Beckham, 2002). Similarly, literature has reported that OEF/OIF Veterans 
with PTSD seek non-mental health related medical services in the VA significantly more 
than both those with other mental health diagnoses and those without any mental health 
issues (Cohen, Gima, Bertenthal, Kim, Marmar, & Seal, 2010).  
 Despite seeing higher use of health services, in general, in the PTSD population, 
receipt of adequate mental health treatment is dismally low among Veterans with PTSD 
entering the VA system of care (Seal et al., 2010). In fact, recent estimates have 
suggested that up to half of service members (Hoge et al., 2014; Quartana et al., 2014) 
and high numbers of Veterans (Ouimette et al., 2011; Tanielian, Jaycox, Adamson, & 
Metscher, 2008) with PTSD do not seek out needed mental health services, and that 
initiation of evidence-based psychotherapy among Veterans with PTSD entering the VA 
system of care is extremely low (Shiner et al., 2013).  
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CHAPTER THREE 
STIGMA, MENTAL ILLNESS, AND CARE SEEKING 
Stigma Theory and Mental Illness 
 Perceived stigma associated with mental illness is an enormous barrier to mental 
health treatment receipt among military personnel (Hoge et al., 2014; Greene-Shortridge, 
Britt, & Castro, 2007) and Veterans (American Psychological Association, 2014) with 
psychological concerns. This is concordant with the underlying stigma theory, which 
postulates that, in order to avoid the stigma associated with mental illness, individuals 
who need mental health care either avoid full participation in care or avoid seeking care 
entirely (Corrigan, 2004). Literature describing the social psychology behind stigma, and 
the effects of perceived stigma on utilization of mental health services, offers several 
potential explanations for why stigma acts as a barrier for treatment seeking behavior.  
 ‘Stigma’ is a social phenomenon in which broad cognitive categories are created 
about particular constructs, and are linked to negative stereotypes about that construct; 
specifically, stigma has been defined as “the co-occurrence of its components – labeling, 
stereotyping, separation, status loss, and discrimination” (Link, & Phelan, 2001). There 
are two main attributions? of mental illness that are associated with the stigmatization of 
mental illness: (1) ‘stability,’ or how easily changed or treated the illness is and (2) 
‘controlability’, or how at-fault the individual is for incurring their illness (Corrigan et al., 
2000). Several common stereotypes that the label of mental illness illicits have been 
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identified, including that individuals who have psychological disorders are to blame for 
their illness, are violent, and are incompetent (Corrigan, 2004). As stereotypes are 
cognitive shortcuts that are often processed in the form of quick judgments about large 
groups of people, stereotypes tend to lead to prejudice, discrimination and the elicitation 
of negative emotions (Corrigan, & Watson, 2002). 
 Thus, being stigmatized leads individuals to experience loss in two important 
domains: self-esteem and social opportunities. Self-esteem is negatively affected in that 
the afflicted individual grows to believe and internalize the stereotypes associated with 
mental illness and social opportunities are negatively affected in that the individual is 
either socially isolated, or regarded with hostility (Greene-Shortridge et al., 2007; 
Corrigan, 2004; Corrigan, 1998). When individuals do not seek treatment for their mental 
illness, they may be doing so to avoid stigmatization both internally and socially which 
they may believe will help avoid loss of self-esteem and social discrimination.  
Therefore, stigma is an important vehicle that is preventing individuals with mental 
health issues from seeking out needed treatment and/or adhering to a treatment regimen 
(Corrigan, 2004).   
Stigma As A Barrier for Treatment Seeking in Veterans and Service Members 
 Recent literature has suggested that there is a vast disparity in the rates of service 
members and Veterans with PTSD who are in need of mental health care and those who 
receive this needed care (Tanielian, Jaycox, Adamson, & Metscher, 2008, Quartana et al., 
2014; Ouimette et al., 2011). Stigma associated with seeking mental health care has been 
cited among the greatest potential barriers to treatment of PTSD in the Veteran 
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population (IOM, 2008). In fact, as few as 23-40% of soldiers and Marines who served in 
the OEF/OIF directives and screened positive for mental health issues post-deployment 
reported having sought out mental health care; these individuals were also found to be at 
increased odds for fear of stigmatization associated with seeking mental health care 
(Hoge, Castro, Messer, McGurk, Cotting & Koffman, 2004). For instance, of those 
Soldiers and Marines who screened positive for mental health issues post-deployment, 
65% reported believing that seeking mental health care would lead them to be seen as 
weak, 63% believed they would be treated differently by work superiors as a 
consequence, 59% believed it would cost them the confidence of their co-workers, and 
41% simply found the idea too embarrassing (Hoge et al., 2004). 
 Several reasons relating to societal and self-stigmatization have been highlighted 
in the literature as reasons that Veterans and service members do not seek out mental 
health care for PTSD, including: desire to avoid a label of being mentally ill (Mittal, 
Drummond, Blevins, Curran, Corrigan, & Sullivan, 2013), not being emotionally ready 
(Stecker, Shiner, Watts, Jones, & Conner, 2013), believing treatment is not necessary 
(Stecker et al., 2013) and that one should be able to deal with one’s own problems 
(Garcia, Finley, Ketchum, Jakupcak, Dassori, & Reyes, 2014), having concerns about 
treatment (e.g., not being understood by providers) (Stecker et al., 2013), believing that 
seeking treatment is a sign of weakness (Garcia et al., 2014), believing one is at fault for 
having PTSD (Mittal et al., 2013), and directly perceiving treatment seeking/receipt as 
stigmatizing (Ouimette et al., 2011; Stecker et al., 2013). Additionally, embarrassment is 
a commonly cited reason among these cohorts for not seeking mental health care, as are 
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ruining chances for promotions within the military and altering the views of one’s peers 
(APA, 2014, Hoge et al., 2004). Recent literature has also suggested a potential link 
between receipt of mental health treatment and subsequent perceptions of mental health 
care associated stigma in OEF/OIF/OND Veterans with PTSD (DeViva et al., 2015).   
 
27 
CHAPTER FOUR 
INTEGRATED MENTAL HEALTH 
Integrated Mental Health and Patient-Centered Care 
 In the United States, mental health issues fuel over 70% of primary care visits 
(National Association of State Mental Health Program Directors (NASMHPD), 2012), 
and individuals with PTSD often seek care in the primary care setting (Stein, McQuaid, 
Pedrelli, Lenox, & McCahil, 2000). As alluded to previously, the Institutes of Medicine 
defined patient-centered care as “care that is respectful of and responsive to individual 
patient preferences, needs, and values, and ensure[s] that patient values guide all clinical 
decisions” (IOM, 2001). Important aspects of patient-centered care include chronic care 
delivery that is aligned with the chronic care model (Gabbay, Bailit, Mauger, Wagner, & 
Siminerio, 2011; Agency for Healthcare Research and Quality (AHRQ), 2010), engaging 
patients in their health care (Bechtel, & Ness, 2010; Epstein, & Street, 2011), including 
patients in shared medical decision-making (Lee, & Emanuel, 2013; Barry, & Edgman-
Levitan, 2012), ensuring that providers exude empathy and communicate clearly and 
effectively with their patients (Bechtel et al., 2010; Epstein et al., 2011), and making sure 
patients receive timely, accessible care that meets their needs and preferences, and leaves 
them satisfied (Barry et al., 2012; Bechtel et al., 2010). According to the Agency for 
Healthcare Research and Quality (AHRQ), effectively managing patient’s mental health 
concerns is integral to patient-centered care delivery (Croghan, & Brown, 2010), and an 
28 
 
effective, patient-centered strategy includes integrating mental health treatment into 
primary care (i.e., ‘integrated mental health’).   
 Integrated mental health models of treatment bring mental health professionals 
into the primary care setting, allowing Veterans to receive comprehensive treatment 
during primary care visits (Veterans Health Administration Support Service Center 
(VSCC), 2011).  This treatment model allows patients to receive behavioral health care 
without needing to follow-up on a referral or having to seek treatment at a specialty care 
clinic (Karlin, & Zeiss, 2010).  The IMH treatment model may reduce stigma associated 
with mental health care seeking and expand access options to to care (Collins, Hewson, 
Munger, & Wade, 2010; WHO, 2008), potentially bridging the gap for Veterans with 
PTSD who need care and those who actually receive it (Corso, Bryan, Morrow, 
Appolonio, Dodendorf, & Baker, 2009; WHO, 2008). Both the VA and DoD have 
recently begun to implement integrated mental health models of care delivery into 
practice (IOM, 2014). 
Models of Integrated Care Delivery 
Care Management and Co-Located Collaborative Care 
The VA, the largest integrated health care system in the country (VHA, 2013), 
began a roll-out of the Primary-Care Mental Health Integration (PC-MHI) initiative (e.g., 
integrated mental health treatment) in fiscal-year ‘07 (Post, Metzger, Dumas, & 
Lehmann, 2010); PC-MHI care models have been rolled out at a number of VA facilities 
(but not all). PC-MHI programs typically have two components: (1) care management, in 
which a care manager (typically a nurse or a social worker) monitors patient’s adherence 
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to mental health treatment, follows up with patients, and attempts to increase engagement 
in and adherence to mental health care, and/or (2) co-located collaborative care, in which 
mental health providers are actually embedded into primary care teams, and provide 
mental health care to patients in the primary care setting; allowing patients with mental 
health concerns to be seen by mental health providers directly in the primary care setting, 
so that the mental health treatment seems like it is part of primary care. Most programs 
have a combination of both components (co-located, collaborative care – CCC) 
(Possemato, 2011).  
 Examples of care management and co-located collaborative care successfully 
implemented within the VA and DoD are as follows: the Behavioral Health Laboratory, a 
VA PC-MHI initiative, utilizes the care management model where health care workers 
conduct diagnostic interviews, refer patients to specialty mental health clinics, and follow 
up with patients regarding their mental health treatment - all via telephone (Pomerantz, & 
Sayers, 2010). The Behavioral Health Consultation (BHC) model, which has been 
utilized in active duty military settings, utilizes a co-located, collaborative care model in 
which primary care providers send patients to mental health providers embedded in the 
primary care setting; the mental health providers conduct diagnostic assessments and 
brief interventions where appropriate, and provide treatment recommendations to 
patient’s primary care providers (who ultimately remain responsible for final care 
decisions) (Corso, Bryan, Morrow, Appolonio, Dodendorf, & Baker, 2009). Similarly, 
the Three Component Model (3CM) used by the Re-engineering Systems for the Primary 
Care Treatment of PTSD (RESPECT-PTSD; RESPECT-Mil) programs is a blended 
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model of integrated care, comprised of both co-located, collaborative care and care 
management used by the DoD, where a psychiatrist is available to carry out consultations 
for primary care providers and manages care managers, on-site care managers follow up 
with patients about their mental health care and are available to answer any questions 
patients may have, and primary care providers/staff are provided with education 
regarding mental health care needs and provision (Engel et al., 2008; Schnurr et al., 
2013).  
Brief Interventions Designed for Use in Primary Care  
In addition to models of integrated mental health care delivery, several brief 
interventions are discussed in the literature as appropriate for use in integrated mental 
health settings, though providing such services in the primary care setting is a somewhat 
new phenomenon (Funderbunk & Shepardson, 2015; Butler et al., 2008). One example of 
this type of intervention is Behavioral Activation (BA); BA is based on the tenets of 
cognitive behavioral therapy, but focuses on re-engaging patients with PTSD in the 
activities that they were conditioned to avoid following trauma exposure (Jakupcak, 
Wagner, Paulson, Varra, & McFall, 2010). Another example is a brief Written Emotional 
Disclosure (WED)/Combat Writing intervention (Possemato, 2011), which involves 
having patients compose written narratives of their traumatic experiences. To facilitate 
use in the primary care setting, these interventions are typically short in terms of length 
and number of sessions required.   
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Differences Between Traditional and Integrated Mental Health Care  
As opposed to usual/traditional mental health care, where a patient is referred to a 
mental health provider/clinic and must follow up on a referral (or seek out a visit of their 
own volition), PC-MHI visits typically begin with a seamless “warm hand-off” from a 
patient’s primary care provider to a mental health provider located in close proximity in 
the primary care setting, if the patient’s primary care provider believes that individual has 
mental health concerns (based on results of brief mental health screenings done by the 
primary care provider or other indications given by the patient), and the patient is 
agreeable to seeing the co-located mental health provider.  
 Visits in this setting (as compared to specialty (usual care/traditional) mental 
health settings), are typically shorter in duration, and patients are usually seen by the 
mental health provider in this setting a fewer number of times (Dundon, Dollar, Schohn, 
& Lantinga, 2011; Possemato, 2011); individuals who require more intensive care are 
then referred out to specialty mental health clinics (usual/traditional care). This type of 
focused, succinct treatment model may greatly improve mental health treatment retention, 
while simultaneously opening up specialty mental health treatment resources to 
individuals who require more intensive care (Pomerantz et al., 2010). 
Use and Outcomes of Integrated Mental Health 
 Recent literature has supported the efficacy of integrated mental health in 
improving symptoms, (e.g., mental health, general health, quality of life) for cohorts with 
various mental health issues such as depression (Kroenke, Shen, Oxman, Williams, & 
Dietrich, 2008; Fortney et al., 2007; Chowdhury, Kulcsar, Gilchrist, & Hawkins, 2012) 
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and generalized anxiety disorder (Roy-Byrne et al., 2010; Chowdhury et al., 2012). For 
instance, receiving integrated mental health treatment has been associated with 
improvements in important health outcomes such as glycated hemoglobin, low-density 
lipoprotein (LDL) cholesterol, and systolic blood-pressure levels in patients with chronic 
conditions (e.g., diabetes, coronary heart disease (CHD), or both) and comorbid 
depression (Katon et al., 2010). Further, a recent review of integrated mental health 
studies in individuals with mental health disorders (mainly depression and anxiety, 
though this review also identified research focused on the use of integrated mental health 
in ADHD, alcohol abuse and somatization cohorts) conducted by the AHRQ found that 
integrated mental health treatment models resulted in greater improvements in depression 
and anxiety symptoms (over usual care), improved quality of life, and higher treatment 
satisfaction (Butler et al., 2008).  
Integrated Mental Health in Veterans/Service Members 
 Literature suggests that integrated mental health may increase likelihood of 
patients receiving an initial (full) diagnostic evaluation for mental health and/or social 
services needed (e.g., beyond the brief screening evaluations that are required for all 
patients) (Seal, Cohen, Bertenthal, Cohen, Maguen, & Daley, 2011). Integrated mental 
health program participation may also improve mental health care continuation among 
Veterans with mental health diagnoses initiating VA care (Bohnert, Pfeiffer, Szymanski, 
& McCarthy, 2013). Integrated mental health is associated with treatment retention in 
mental health care (Tsan, Zeber, Stock, Sun, & Copeland, 2012), adherence to 
pharmacological treatment in Veterans with depression (Fortney et al., 2011) and 
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increased utilization of specialty mental health services (Wray, Szymanski, Kearney, & 
McCarthy, 2012), as treatment modalities may still fall under the specialty care umbrella 
and/or patients may be more likely to follow up on referrals for care in specialty mental 
health clinics, indicating use of needed/prescribed services. Additionally, recent studies 
have found that integrated mental health treatment models may optimize recognition and 
diagnosis of mental health disorders (Zivin et al., 2010), and reach typically underserved 
populations in behavioral health care (Johnson-Lawrence et al., 2012) in the Veteran 
population.  
 Integrated mental health treatment delivery has been shown to decrease pain and 
depression severity in Veteran patients with chronic pain receiving care from the VA 
(Dobscha et al., 2009). Further, a study by Cucciare and colleagues (2013) found that a 
brief behavioral health intervention delivered in primary care to Veterans with substance 
abuse (specifically, alcohol) may foster improvements in use of appropriate coping 
mechanisms, depression severity, and mental health status (as compared to usual care) 
(Cucciare, Boden, & Weingardt, 2013).   
Integrated Mental Health and Veterans/Service Members with PTSD 
 Among the factions that comprise the DoD, all service branches are implementing 
integrated mental health programs in order to reduce barriers to mental health care for 
members of the military (including those with PTSD) (IOM, 2014). Additionally, as 
mentioned, the VA health care system began rolling out integrated mental health care in 
facilities throughout the national health care system in FY07 (Post, Metzger, Dumas, & 
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Lehmann, 2010). Despite the need, however, limited evidence exists about the effects of 
integrated mental health treatment delivery in Veterans and service members with PTSD.  
 Gellis et al. (2010) examined mental health diagnoses, PTSD symptom severity, 
depression severity, and health status in 201 OEF/OIF Veterans with PTSD receiving 
care from the Behavioral Health Laboratory (BHL) at the Philadelphia and Lebanon VA 
Medical Centers (VAMCs). The Veterans in the study sample (receiving care via the 
BHL) were classified as having full (e.g., meet diagnostic criteria as outlined by the 
DSM) (59.7%) or partial (e.g., have PTSD symptoms but do not meet full DSM 
diagnostic criteria; ‘sub-threshold’ PTSD) (18.4%) PTSD, or minimal/no PTSD 
symptoms (despite having experienced trauma (21.9%)). Physical health status was 
similar across PTSD groups, but composite mental health scores were worse in Veterans 
with full PTSD (vs. partial and no PTSD). Veterans with full PTSD reported significantly 
worse depression symptoms than those with partial PTSD (whose depression scores were 
also worse than Veterans with no PTSD). Presence of comorbid panic disorder and 
bipolar disorder were associated with PTSD classification (Gellis, Mavandadi, & Oslin, 
2010).  
 Similarly, Kornfield and colleagues (2012) examined PTSD symptom severity, 
severity of comorbid depression, and health status in Veterans with sub-syndromal PTSD 
receiving IMH care through the BHL at the Philadelphia VAMC. This cohort of 
Veterans, who received care via the IMH treatment model, did not meet full diagnostic 
criteria for PTSD, but scored between 40-60 on the PTSD Checklist – Civilian Version 
(PCL-C) and reported having experienced trauma. Outcomes were examined overall, and 
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comparisons were made between OEF/OIF/Operation New Dawn (OND) Veterans and 
non-OEF/OIF/OND Veterans. Comorbid depression was reported in approximately 44% 
of the sample, however, it was less prevalent in the OEF/OIF/OND cohort (36.7%) than 
the non-OEF/OIF/OND cohort (47.9%). Of the overall sample, only 28% endorsed 
avoidance symptoms, 80% endorsed arousal symptoms, and 86% endorsed re-
experiencing symptoms. A greater proportion of the OEF/OIF/OND Veterans endorsed 
arousal symptoms, while a lesser proportion endorsed avoidance symptoms; there were 
no differences in frequency of re-experiencing symptom cluster endorsement. Not 
surprisingly, OEF/OIF/OND Veterans reported better physical health scores than the non-
OEF/OIF/OND cohort, while mental health was similar across Veterans groups 
(Kornfield, Klaus, McKay, Helstrom, & Oslin, 2012). 
 Brawer and colleagues (2011) conducted a retrospective chart review of 471 
OEF/OIF Veterans who received consults to the OEF/OIF-specific PTSD clinic at the St. 
Louis VAMC between 01/01/2009 and 06/30/2010. Outcomes examined were consult 
completion, consult accuracy (diagnostic and administrative accuracy), length of 
engagement in care prior to consultation, and PTSD symptom severity and depression 
severity (at time of consult). Veterans whose consults were placed by PC-MHI providers 
were compared to those who received consults from PCPs, specialty mental health, or 
providers from other parts of the hospital (e.g., emergency department, medical clinics). 
Veterans referred by PC-MHI providers (vs. other provider types) did not differ in terms 
of PTSD and depression severity, and number of clinic visits prior to consultation. 
Significantly more Veterans referred to the OEF/OIF PTSD clinic by PC-MHI providers 
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(vs. PCPs) completed their consults and had accurate consults administratively, however, 
no differences in diagnostic accuracy of consults placed by PC-MHI providers (vs. PCPs) 
were found (Brawer et al., 2011).  
 Similarly, Possemato et al. (2011) conducted retrospective chart reviews to 
examine need for treatment (positive VA mental health screens), physical and psychiatric 
health conditions, service use and prescribed medications in Veterans with PTSD 
receiving PC-MHI services compared to those receiving specialty mental health or 
primary care services only. PTSD was most commonly addressed in PC-MHI sessions 
(main focus in 72% of session), with mood (42%) and anxiety (13%) disorders the next 
most common. Veterans who started in PC-MHI and switched to specialty mental health 
(vs. those who stayed in PC-MHI) were more likely to be Vietnam Veterans, service 
connected, had more psychiatric diagnoses and PTSD visits, and were prescribed more 
medication (Possemato et al., 2011). 
 Additionally, Vojvoda and colleagues (2014) conducted a retrospective cohort 
administrative database analysis comparing Veterans with PTSD who received integrated 
mental health treatment in primary care to those who received care through specialty 
mental health clinics. Contradictory to previous studies, results indicated that most 
Veterans were seen in specialty mental health clinics, and the authors postulate that 
stigma may not, in fact, be driving Veterans with PTSD to seek out mental health care in 
the primary care setting. Results did, however, show that more Veterans receiving their 
care in specialty mental health clinics were receiving pharmacological treatment (vs. 
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Veterans receiving integrated mental health care) (Vojvoda, Stefanovics, & Rosenheck, 
2014).  
 Recently, Bohnert et al. (2016) also conducted a retrospective cohort 
administrative database study, wherein records for over 21,000 Veterans who screened 
positive for PTSD and received either primary care, PCMHI, or specialty mental health 
care on the day of screening. Findings indicate that being seen by a PCMHI provider on 
the day of a positive PTSD screen was associated with greater odds of being diagnosed 
with PTSD, and initiating treatment for PTSD (Bohnert, Sripada, Mach, & McCarthy, 
2016).   
 Further, Hoerster and colleagues (2015) adapted the Translating Initiatives for 
Depression into Effective Solutions (TIDES) model of care management for Veterans 
with depression for use in OEF/OIF Veterans with PTSD (TIDES/PTSD). The care 
management program was delivered via telephone to 17 OEF/OIF Veterans with PTSD. 
Results indicated high patient satisfaction, and decreased PTSD symptom severity, 
following participation in the program (Hoerster et al., 2015).  
 A small number of studies have also examined outcomes for Veterans who 
received integrated mental health treatment through a treatment model adapted from the 
RESPECT-D framework, an integrated treatment model (3CM) that was shown to be 
effective in treating depression. Schnurr et al. (2013) found no differences in PTSD or 
depression severity change in Veterans who received 3CM compared to those who 
received usual care. However, Veterans who participated in the intervention had higher 
mental health care utilization and rates of filling prescriptions for antidepressant 
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medication. While many Veterans rated the care they received through 3CM highly, the 
intervention arm was associated with lower perception of PTSD-specific care.  
 Among a cohort of active duty military personnel, however, Engel and colleagues 
(2008) found that, in individuals who received 3CM treatment, clinically significant 
reductions in PTSD symptom severity were realized in 67% of participants at 6-10 week 
follow-up and 81% at 12-week follow-up, and clinically significant reductions in 
depression were realized in 48% of participants at 6-10 week follow-up and 63% at 12-
week follow-up. Only about 21% of this sample, however, had PTSD, indicating that 
findings may not be entirely generalizable to the PTSD population.  
 Additionally, a handful of studies have examined outcomes among active duty 
military personnel receiving collaborative mental health/primary care. Cigrang and 
colleagues (2011) reported that, among active duty OEF/OIF personnel, PTSD and 
depression severity, along with global mental health functioning, improved following 
integrated mental health treatment. In fact, of those who completed treatment, half no 
longer met diagnostic criteria for PTSD at follow-up. Currently, the first randomized 
controlled trial examining implementation of integrated mental health in service members 
with PTSD and/or depression is underway, and will provide outcomes and impact of 
internally facilitated vs. externally facilitated integrated mental health (Engel et al., 
2014).  
 A number of studies have also examined the effects of brief mental health 
interventions designed for use in and administered in primary care for cohorts of 
Veterans/service members with PTSD. Corso et al. (2009) examined two brief 
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interventions (5 sessions of combat writing or impact statement compared with usual 
care) delivered in an integrated mental health setting on PTSD symptoms and global 
mental health in active duty military personnel. Significant reductions in PTSD severity 
and global mental health following treatment were realized. Specifically, individuals who 
received the impact statement intervention experienced significant reductions in PTSD 
symptoms and global mental health, written emotional disclosure participants 
experienced a reduction in PTSD symptoms (but non-significant) and, surprisingly, a 
decline in global mental health (but also non-significant), and usual care receipt resulted 
in no symptoms change for PTSD or global mental health. 
 Additionally, several studies have examined outcomes among Veterans with 
PTSD who received brief mental health interventions delivered in (or designed to be 
delivered in) primary care settings. Harmon et al. (2014) examined the effectiveness of a 
brief (three to four 20-minute sessions) trauma intervention with cognitive-behavioral 
therapy components delivered in a VA PC-MHI clinic. Of their sample, approximately 
82% were diagnosed with PTSD. No significant improvements in PTSD severity were 
found, but decreases in severity of depression and anxiety were realized. Additionally, 
improvements in subsequent specialty mental health treatment engagement were 
reported.  
 Jakupcak and colleagues (2010) examined the effects of a behavioral activation 
(BA) intervention provided in the primary care setting on PTSD severity in OEF/OIF 
Veterans with PTSD and depression. The BA intervention consisted of 8 treatment 
sessions. Significant decreases in PTSD symptoms over time, as measured by both the 
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Clinician-Administered PTSD Scale (CAPS) and the PCL-Military Version (PCL-M), 
were seen in Veterans who received the BA intervention; these effects were true for both 
Veterans who completed all 8 sessions of the intervention and those who completed only 
4 sessions. Of the 5 Veterans who completed all 8 sessions, symptom reduction was 
maintained at 3-month follow-up in 4. Reduction in depression severity and increase in 
reported quality of life were reported for study participants, but were not significant. 
Additionally, reported satisfaction with care was high among Veterans who received this 
treatment.  
 Similarly, Plagge and colleagues (2013) examined the effectiveness of an 
integrated treatment intervention with BA (IMPROVE) for OEF/OIF/OND Veterans with 
PTSD and comorbid chronic pain. Comparing pre-treatment to post-treatment levels, 
Veterans reported decreases in PTSD symptom severity, pain severity, and pain 
interference. Veterans who completed the intervention also reported improvements in 
depression, quality of life and satisfaction with life, and pain catastrophizing and 
kinesiophobia. Veterans also reported high levels of satisfaction with treatment. 
 Possemato et al. (2011) reported PTSD and depression severity, problematic 
alcohol use, health status and participant satisfaction in a group of OEF/OIF Veterans 
who participated in a brief intervention comprised of written emotional disclosure 
delivered via telehealth. No significant differences were found in outcomes from pre-to-
post-intervention, however, authors mention that a lack of sufficient power may have 
caused inability to detect meaningful differences even if they were there.   
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CHAPTER FIVE 
STUDY OBJECTIVES 
The primary purpose of this study was to examine the impact of a novel model of 
mental health care delivery, integrating mental health into primary care, on outcomes of 
Veterans with PTSD receiving care from the VA health care system. This model of care 
has been cited as a potential way to reduce stigma attached to seeking mental health care, 
which in turn may increase health care seeking, treatment engagement, and expand access 
options to care. In the literature, integrated mental health treatment models have shown 
positive impacts on mental and physiological health outcomes, and appropriate health 
care utilization, in civilian cohorts with mental illnesses, as well as Veterans and service 
members with psychological health concerns. Some recent research has indicated that this 
treatment model may have positive mental and physical health, and appropriate health 
care utilization, effects on individuals with PTSD, including Veterans and service 
members. Despite the importance, however, evidence of the impact of this relatively new 
and potentially beneficial model of health care delivery in Veterans and service members 
with PTSD is scarce. Using several methods of data collection (e.g., medical chart 
reviews, VA administrative databases, surveys) the overall goal of the present study was 
to assess the impact of integrated mental health care (as compared to usual mental health 
care) on important health, treatment utilization and patient-centered care outcomes in a 
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national sample of Veterans with PTSD who received treatment in the VA health care 
system and were new users of mental health care.  
Hypotheses 
Hypothesis 1 
Veterans with PTSD receiving integrated mental health care (vs. Veterans with 
PTSD receiving usual mental health care) will have more appropriate mental health care 
utilization, better physical and mental health outcomes, lower pain, and lesser PTSD 
symptoms. 
 Hypothesis 1a. Veterans with PTSD receiving integrated mental health care (vs. 
Veterans with PTSD receiving usual mental health care) will have more appropriate 
mental health care utilization. More appropriate mental health care utilization was 
defined as: more needed mental health visits, prescribed pharmacology use, fewer 
hospitalizations, but more primary care visits. Literature indicates that receiving IMH 
care is associated with mental health care continuation among Veterans with mental 
health diagnoses initiating VA care (Bohnert, Pfeiffer, Szymanski, & McCarthy, 2013), 
treatment retention in mental health care (Tsan, Zeber, Stock, Sun, & Copeland, 2012), 
adherence to pharmacological treatment in Veterans with depression (Fortney et al., 
2011) increased utilization of specialty mental health services (Wray, Szymanski, 
Kearney, & McCarthy, 2012), decreased preventable hospitalizations among Veterans 
with mental illness (Pirraglia, Kilbourne, Lai, Friedmann, & O’Toole, 2011), increased 
primary care and specialty medical care visits, but no differences in ER visits,  among 
Veterans with depression (Engel, Malta, Davies, & Baker, 2011). 
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 Hypothesis 1b. Veterans with PTSD receiving integrated mental health care (vs. 
those receiving usual mental health care) will have better physical health (e.g., fewer 
visits with poor health indicators, higher self-reported physical health (VR-12) scores 
(where available) and lower pain scores (as recorded in the patient’s medical record). 
Poor health indicators were defined as diastolic blood pressure ≥ 90 and systolic blood 
pressure ≥ 140 (hypertension); Hemoglobin A1c ≥9% (diabetes); LDL ≥ 130 
(Hyperlipidemia). Less pain was defined as the average pain rating (0-10 scale) provided 
by patients during their medical visits, as recorded in the patient’s medical record. 
Literature indicates that receiving care via the IMH treatment model has been associated 
with improvements in important health outcomes such as glycated hemoglobin A1c, 
cholesterol, and blood-pressure levels in patients with chronic conditions (e.g., diabetes, 
coronary heart disease (CHD) or both) and comorbid depression (Katon et al., 2010). 
Additionally, literature indicates that IMH treatment delivery has been shown to decrease 
pain in Veteran patients (Dobscha et al., 2009). 
 Hypothesis 1c. Veterans with PTSD receiving integrated mental health care will 
have lower depression symptom severity (where applicable), and higher self-reported 
mental health scores (VR-12; where available) than Veterans with PTSD receiving usual 
mental health care. Depression severity was defined as the patient’s last recorded PHQ-9 
score (as recorded in the patient’s medical record, when available).  Literature indicates 
that receiving care via the IMH treatment model may help to relieve symptoms of 
depression in Veteran patients receiving VA health care (Dobscha et al., 2009). 
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 Hypothesis 1d. Veterans receiving integrated mental health care will endorse 
fewer PTSD symptoms, and have lower overall symptom severity, than Veterans 
receiving usual mental health care. For this hypothesis, PTSD symptoms were derived 
from provider progress notes recorded in the patient’s medical record, as classified by the 
DSM V diagnostic criteria, and may have included symptoms of avoidance, intrusion, 
negative alterations in cognitions and mood, and/or alterations in arousal and reactivity.  
Symptom severity was defined as PTSD-Checklist (PCL) scores, as recorded in the 
patient’s medical record, where available. Literature indicates that treatment receipt via 
an IMH model reduces PTSD symptom severity in active duty military personnel (Engel 
et al., 2008; Cigrang et al., 2011).  
Hypothesis 2  
Patient perceptions of patient-centered care constructs will be higher among 
Veterans with PTSD receiving integrated mental health care than those receiving usual 
mental health care Patient perceptions of patient-centered care constructs were defined as 
patient’s CEPEP survey responses for the following constructs: care alignment with the 
chronic care model as measured by the Patient Assessment of Chronic Illness Care scale, 
treatment engagement as measured by the Patient Activation Measure, provider empathy 
and patient-provider communication as measured by the Consultation And Relational 
Empathy measure, overall experience with the health care facility as measured by the 
Global Practice Experience measure, shared decision-making as measured by the 
Combined Outcome Measure for Risk Communication and Treatment Decision Making 
Effectiveness, and respect for choices and support as measured by the Press-Ganey 
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questions. Though literature examining patient-centered care outcomes in relation to 
IMH treatment receipt is sparse, hypothesized differences between cohorts in this study 
are expected because the IMH treatment model is a patient-centered model of mental 
health care delivery, indicating that Veterans with PTSD receiving IMH care should 
receive care that is more patient-centered compared to Veterans receiving usual mental 
health care.  
Hypothesis 3  
Veterans receiving integrated mental health care will be recommended to more 
psychotherapy and CAM treatment options by their providers, whereas Veterans 
receiving usual mental health care will be recommended to more pharmacology treatment 
options. Literature indicates that more Veterans with PTSD receiving their care in 
specialty mental health clinics were prescribed pharmacological treatment (vs. Veterans 
receiving integrated mental health care), as evidenced by greater number of psychotropic 
prescriptions filled (Vojvoda, Stefanovics, & Rosenheck, 2014). 
Hypothesis 4  
As one of the central tenets of PCC within the VA health care system is that 
health care will be personalized, proactive, and take into account what matters most to 
patients, patient preferences for treatment will be taken into consideration by providers 
more often for Veterans receiving integrated mental health care (vs. usual mental health 
care).  Assessment of patient preferences for treatment were made based on a 
comprehensive assessment of the content of progress notes across the course of 
treatment; an example of a patient preferences is if a patient tells their provider that they 
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do not wish to participate in pharmacological treatment because they medication they are 
on gives them side-effects; the provider may either accommodate the patient’s preference 
(e.g., recommend an alternative, non-pharmacological treatment option) or recommend 
treatment that is not concordant with what the patient wants (e.g., insist the patient stays 
the course of the medication). 
Hypothesis 5 
Patient perceptions of two important patient-centered care constructs associated 
with health services utilization, including mental health services (e.g., shared decision-
making; patient activation) will mediate the relationship between type of mental health 
treatment (integrated vs. usual care) and receipt of necessary recommended PTSD 
treatment (9 or more visits within 1 year of treatment initiation). 
 
47 
CHAPTER SIX 
METHODS 
This quasi-experimental study used mixed methods to evaluate the impact of 
integrative mental health treatment delivery on physical health, mental health, PTSD, 
health services utilization, patient perceptions of patient-centered care, provider 
recommendations for treatment, and considerations of patient preferences for treatment.   
 Under the supervision of Dr. LaVela, a team of Health Services Research and 
Development (HSR&D) researchers at the VA conducted a large-scale, national 
evaluation study to examine the spread and reach of patient-centered care innovations in 
the VA system of care [Center for Evaluation of Practices and Experiences of Patient-
Centered Care (CEPEP), PEC 13-002, PI: LaVela]. This project was classified as a 
Quality Improvement project by the VA Central IRB. 
 A portion of the current study involved a survey comprised of measures of several 
patient-centered care constructs, which was mailed to Veterans who had received care at 
one of 8 VA health care facilities nation-wide, from mid-FY12 (May 2012) through 
11/15/2012. This study drew upon Dr. LaVela’s evaluation. The population for the 
current study began with the larger general Veteran cohort to which CEPEP surveys were 
mailed (our initial pool of eligible Veteran patient participants).  
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Participants 
 Of the 16,425 Veterans that comprised the final CEPEP sample, individuals that 
were included in the cohort of participants for the present study were identified using the 
following method (please see Table 1): 
 (1) Veterans who had two documented PTSD diagnoses (2 instances of the ICD-9 
code 309.81 in their medical record, which is the diagnosis code for PTSD) from the 
beginning of FY12 (October 1, 2011) – 12/31/2012 were identified using VA Inpatient 
and Outpatient administrative data.  
 (2) Integrative Mental Health users were identified as individuals who had a 
documented clinic stop of 534 or 539 in either the primary or credit position, or credit 
pairs 527/534, 182/534, 323/531, from the beginning of FY12 – 12/31/2012. Clinic stop 
codes are used within the VA to document and track patients’ use of specific outpatient 
health services, and can be coded as a single number or a pair of numbers, where the first 
number is said to be in the primary position and the second number is said to be in the 
credit position; when a code is in the primary position, this indicates that the primary 
reason for the visit was use of that particular service. When the code is in the credit 
position, this indicates that the use of that service was the secondary reason for the visit. 
The first integrated mental health care visit in that time frame was used as the index visit, 
and all subsequent mental health visits were considered ‘integrated’ care.  
 (3) ‘Usual Mental Health Care’ users were identified as individuals who had a 
documented clinic stop code of 502-599 (the clinic stop codes for mental health care 
visits, e.g., care received at mental health clinics) from the beginning of FY12 (October 
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1, 2011) – 12/31/2012, excluding 586 and 587 (residential care) and any credit pair of a 
stop code in the 500s with 534 or 539 in the credit position (such that no individuals who 
were in the integrated mental health group were included in the usual care group). The 
first mental health visit in that time frame was used as the index visit; of our pre-
identified cohort of eligible study participants, 112 Veterans were excluded because they 
had no Mental Health care during the timeframe. 
 (4) Individuals were identified as ‘new users’ of mental health care if they had not 
had a previous mental health visit in the two years preceding, leaving 311 Veterans 
eligible Veterans (126 integrated mental health care users and 185 usual mental health 
care users); Veterans who had used both integrated mental health and specialty mental 
health services were considered to fall into the integrated mental health care group, as all 
care subsequent to integrated mental health care initiation should be integrated. 
Table 1. Sample Derivation 
CEPEP sample with 2 PTSD flags  
PTSD 2213 
No PTSD 13960 
 CEPEP sample with 2 PTSD flags by mental health care use 
Integrated Mental Health 551 
Usual Mental Health Care 2027 *1550 
CEPEP sample with 2 PTSD flags and no mental health care use in 2 years prior to index 
date 
Integrated Mental Health 126 
Usual Mental Health Care 289 *185 
*Represents Usual Mental Health Care only 
 
 (5) In order to better ensure that groups for comparison were equivalent, and to 
rule out potential selection effects which may have been present due to the quasi-
experimental nature of the study, patients in the usual mental health care group were 
matched on age and number of comorbid mental health conditions to patients in the 
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integrated mental health care group. Comorbid mental health conditions were identified 
by ICD-9 codes in the range of 290-319 present in the patient’s medical record, which is 
the range of ICD-9 codes used to document diagnosis of mental health conditions. The 
final sample was 234 Veteran patients (117 in each group). [Please see Figure 1 for a 
flow-chart delineating the population selection process] 
Procedure and Materials 
 Data for the current study were obtained from several sources: VA administrative 
data, medical record chart review, and the mailed national patient survey conducted as 
part of the CEPEP evaluation efforts. See Appendix A for a table detailing variables and 
sources (which are also described below).   
Administrative Data  
Information regarding health services utilization, select comorbid mental and 
physical health conditions, and demographics was obtained from VA administrative 
databases (and supplemented with CEPEP survey data (in the case of demographics)), 
where available, to minimize the amount of missing data. The VA Corporate Data 
Warehouse (CDW) is a national database comprised of data from VHA clinical and 
administrative systems, which are stored such that all data can be merged at the patient 
level. Data included in the CDW include information about all inpatient and outpatient 
care, as well as the content of patient’s electronic health records. CDW data are refreshed 
nightly, allowing close monitoring of included data, such as utilization trends. 
Administrative data collected in the CDW was pulled and analyzed for all 234 Veterans 
in the final cohort of this study.  For this study, the CDW was used to capture 
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demographic data, chronic conditions, mental health diagnoses, mental health and general 
health services utilization, and physical and mental health indicators. 
Medical Chart Abstraction  
Information regarding severity of comorbid mental health conditions, frequency 
and severity of PTSD symptoms, and provider recommendations for treatment was 
obtained via medical chart review abstraction. Medical chart reviews are a data collection 
method which involves scanning progress notes in patient’s medical records for data 
relevant to health care and health care visits (Jaén et al., 2010), For the current study, 
medical chart reviews were conducted to gather additional information related to 
participant’ PTSD symptoms, providers’ treatment recommendations (and patient 
preferences for treatment), and severity of comorbid mental health conditions, 
information which is not available via administrative databases. The content of 
physicians’ and nurses’ notes, documented in patient’s electronic health record, may offer 
additional detail about the frequency and severity that participants experienced PTSD 
symptoms, as well as provider referrals to various potential treatment options (e.g., 
pharmacology, psychotherapy, CAM), and details about the trajectory of any mental 
health comorbidities the patient may be experiencing. 
 Medical chart reviews were conducted with a random sample of 45 individuals 
from the integrative mental health group and 45 individuals from the usual mental health 
care group (90 chart review ‘participants’ total). Chart reviews started with an index date 
(the patient’s first integrated mental health or usual mental health care visit); all mental 
health and primary care notes were reviewed from the index date through the subsequent 
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year. Data were systematically extracted using a form developed by the researcher 
(Etingen), which was revised based on several test cases (see Appendix B).  For each 
patient participant, one ‘cover sheet’ was filled out overall, and one chart review form 
was completed for each visit that the patient has in the chart review time period.  
 In order to assess inter-rater reliability, a 10% sample of the chart reviews were 
conducted by an independent member of the research team; a reliability check was then 
done to make sure both individuals were conducting the chart reviews in the same way.  
An a-priori criterion of 85% inter-rater reliability was set for the overall chart review 
assessment tool. Inter-rater reliability was investigated by calculating the proportion of 
agreement (or the number of times the two reviewers agreed on the presence or absence 
of the criterion in each of the notes); agreement between the two reviewers was very 
high, with an overall proportion agreement of 98%. 
Survey Data  
Information on self-reported health status and patient perceptions of several 
patient-centered care constructs was obtained for a sub-set of the sample using data from 
the mailed national survey conducted as part of the CEPEP evaluation efforts. The 
CEPEP patient survey was sent to a national sample of Veteran patients in 
February/March of 2013. The survey packet was comprised of several measures of 
patient-centered care constructs, and was sent along with a cover letter explaining the 
study and a postage paid return envelope to facilitate ease of response. A follow-up 
mailing was conducted in May/June of 2013 with non-respondents, to facilitate response.  
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 Surveys were sent to 16,425 general Veteran patients. The denominator was 
adjusted to 15,629, as 674 surveys were returned as undeliverable, 77 Veterans on the 
initial mailing list were deceased, 42 Veterans indicated the survey was not applicable to 
them, and 3 surveys were returned to us unopened. Surveys were returned by 5,512 
Veteran patients (35.27% response rate).  Of our cohort, completed surveys were 
available for 30 Veterans in the integrated mental health group and 31 Veterans in the 
usual mental health care group (n=61 Veterans total).  
Measures/Variables 
Demographics, Veteran Characteristics and Select Health Conditions  
Demographic and characteristic variables collected were: gender (male, female); 
age; race (white, black, Asian, native Hawaiian/ other Pacific Islander, American 
Indian/Alaska Native, other); ethnicity (Hispanic/Latino, non-Hispanic/Latino); 
relationship/marital status (married, not married); service connected disability percentage 
(0%, 1-49%, 50-100%), number of select chronic conditions; multimorbidity (≥2 chronic 
conditions); and select mental health diagnoses. Chronic conditions assessed and 
included in the count used to identify multimorbidity were based on 5 chronic conditions 
indicated by the CDC as being among the top causes of mortality in the US, and 
included: heart disease, cancer, chronic lower respiratory disease, stroke and diabetes 
(CDC, 2013). ICD-9 codes (slightly modified from those used by Jemal and colleagues, 
2005) used to identify presence of these disorders can be found in Appendix A (Jemal, 
Ward, Hao, & Thun, 2005).  
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 Comorbid mental health diagnoses were obtained via administrative data. For 
these psychosocial disorders, ICD-9 codes, classified into groups using the general 
classifications documented in the Agency for Health Research and Quality’s (AHRQ) 
Clinical Classifications Software (Elixhauser, Steiner, & Palmer, 2008), a method that 
has been previously used to examine mental health diagnoses in Veterans, with minor 
adjustments (e.g., examining PTSD on its own rather than with other anxiety disorders; 
combining alcohol and substance use disorders; examining bi-polar and depressive 
disorders separately rather than combined as the more general group of ‘mood disorders’) 
(Pavao et al., 2013).  Mental health diagnoses examined included: adjustment disorders, 
anxiety disorders, PTSD, impulse control disorders (including pathological gambling), 
bipolar disorders, depressive disorders, personality disorders, schizophrenia and other 
psychotic disorders, substance use disorders, and suicide and intentional self-injury. 
Information on whether or not Veterans had a documented history of military sexual 
trauma was also be collected. (See Appendix A for a full description of ICD-9 codes 
included in each diagnosis category). 
Health Services Utilization 
Utilization variables assess whether integrative mental health fosters an increase 
in adequate mental health care utilization (defined as 9 or more mental health treatment 
visits within 12 months of the patient’s index visit for patients with PTSD; Lu, Duckart, 
O’Malley, & Dobscha, 2011). Mental health utilization was examined through the 
following indicators: outpatient visits related to mental health services, prescription 
psychotropic medication fills, and visits specifically associated with a number of mental 
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health conditions (a visit was considered to be for a particular condition if the primary 
diagnosis code for that visit was an ICD-9 code for that condition). 
 Further, data on general health care utilization (including mental health care 
utilization, which was also pulled out and reported separately) was also be examined, and 
included: inpatient encounters (hospitalizations); average length of stay; outpatient visits 
(general) and specifically primary care visits [and number of no-shows to scheduled 
primary care visits]; emergency department visits; prescription medication fills (general). 
Additionally, patients’ number of visits for several select physical were tracked (a visit 
was considered to be for a particular condition if the primary diagnosis code for that visit 
was an ICD-9 code for that condition).  
Physical Health 
Proxy measures (indicators) of physical health were obtained via administrative 
databases, and included: blood pressure (hypertension); Hemoglobin A1c (diabetes); 
LDL (Hyperlipidemia). The number of visits associated with indicators of poor health for 
these conditions were recorded. For blood pressure, systolic blood pressure ≥ 140 and 
diastolic blood pressure ≥ 90 indicates poor health (American Heart Association, 2014). 
For Hemoglobin A1C: HbA1c ≥9% indicates health (US Department of Health and 
Human Services). For Low Density Lipids (LDL): LDL ≥ 130 indicates poor health 
(National Heart, Lung and Blood Institute, 2005). Pain severity was measured using a 0-
10 rating scale. Patients are asked to rate, on a scale of 0 to 10, how much pain they are 
currently in. Scoring is as follows: 0=no pain, 1-3=mild pain, 4-6=moderate pain, 7-
10=severe pain (Jones, Vojir, Hutt, & Fink, 2007). 
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Mental Health Comorbidities  
Information regarding the symptom severity of a mental health comorbid 
condition typically experienced along with PTSD (e.g., depression) was assessed through 
medical chart reviews. Specifically, provider’s progress notes often include, as 
appropriate, scores on several clinical measures of mental health issues. The assessment 
scores most commonly utilized among VA providers for depression, where available, 
were recorded for each patient: Depression severity, most commonly assessed among VA 
providers using the PHQ-9, was recorded when available. The PHQ-9 is a 9-item 
measure used to assess depression severity. Patients are asked to think about the last 2 
weeks, and report how much they were bothered by the problems inquired about in the 
questions. Response options are on a 4 point scale, and include 0 (not at all), 1 (several 
days), 2 (more than half the days), 3 (nearly every day). Scores are added together for a 
total depression severity score (University of Michigan Health System (UMHS), 2011).  
PTSD Symptoms  
Symptom endorsement was assessed using the revised DSM-V diagnostic 
criterion; patient’s progress notes were scanned for mention of or diagnostic assessments 
of PTSD symptoms that the patient is experiencing. Symptom clusters and individual 
symptoms were recorded. PTSD symptom severity was assessed using the PTSD 
Checklist (PCL) (see Appendix C); PCL scores were also be extracted from patient’s 
medical records, where available. The PCL is a 17-item measure which asks patients 
about their experiences with PTSD symptoms; response options are on a 5-point scale, 
and range from 1 (not at all) to 5 (extremely). PCL scores range from 17-85, with PTSD 
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severity levels classified as follows: <40 indicates non-significant symptoms, 40-50 
indicates moderate symptoms, and >50 indicates severe symptoms. A change of at least 5 
points on the PCL indicate response to treatment, and a change of at least 10 points 
indicates a clinically significant improvement (National Center for PTSD, 2012). 
Self-Reported Health Status  
A self-report measure of health status was included with the CEPEP survey; the 
Veterans RAND 12-Item Health Survey (VR-12) is a validated, reliable measure of 
health status. The VR-12 produces two summary scores: mental health and physiological 
health. The scale consists of 12 questions, and is scored based on guidelines provided by 
the scale’s developers; higher scores indicate better health status (Kazis, Selim, Rogers, 
Ren, Lee, & Miller, 2006). Self-reported health status was compared in the sub-set of 
patients for whom CEPEP survey data were available.  
Perceptions of Patient-Centered Care Constructs  
The integrative mental health treatment model is geared toward ensuring the 
delivery of patient-centered care, and as such, this study assessed patient perceptions of 
several important patient-centered care constructs, as collected via the CEPEP survey 
(see Appendix D), in a sub-set of patients for whom CEPEP survey data were available. 
Patient-centered care constructs measured included: 
 Global Practice Experience (GPE). Designed for the evaluation of the Patient-
Centered Medical Home National Demonstration Project, the GPE is a 2 question scale 
which provides an all-or-nothing rating of patient’s satisfaction with their experience at 
their health care facility (Jaen et al., 2010; Nutting et al., 2010), and is based on Institute 
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of Medicine criteria (IOM, 2001). Questions are: ‘I receive exactly the care I want and 
need when and how I want and need it’ and ‘I am delighted with this practice’. Response 
options range from ‘strongly disagree’ to ‘strongly agree’; scores provided are the 
proportion of patients who provide a ‘full successful’ rating, which is given only when 
the patient provides a ‘strongly agree’ response to both questions.  
 Consultation and Relational Empathy (CARE). The CARE is a valid and 
reliable 10-item scale that assesses patient’s perceptions of provider’s empathy and 
patient-provider communication (Mercer, & Reynolds, 2002; Mercer, Maxwell, Heaney, 
& Watt, 2004). While the original CARE measure’s questions referred to a specific 
consultation, we adapted the wording such that questions better fit the experience of care 
in the VA, altering ‘consultation’ to ‘visit’ or ‘clinical encounter.’  Questions include:  
How was the provider at. . . ‘making you feel at ease?’, ‘…letting you tell your “story?”’, 
‘…making a plan of action with you?’ Response options are on a 5 point scale, and range 
from 1 (poor) to 5 (does not apply); each question also has a ‘does not apply’ option 
available. Scores are added, and range from 10 to 50; the scale may still be scores with up 
to 2 ‘does not apply’ or missing values. Higher scores reflect higher perceptions of 
provider empathy and patent-provider communication.   
 Patient Activation Measure (PAM). The PAM (Hibbard, & Mahoney, 2005) is a 
13-item valid and reliable instrument that measures patients’ engagement in their health 
care. Using a 4-point scale (response options ranging from ‘strongly disagree’ to 
‘strongly agree’), patients are asked to rate their level of agreement with statements 
reflecting the stages of activation, which represent a 4-stage developmental process of 
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activation. Responses are added, and using a conversion table designed by the scale’s 
developers, those raw scores are converted into an overall patient activation score, which 
ranges from 0-100 (if there are missing responses, take the mean of the answers provided 
and multiply by 13 prior to concerting the scores). Patient activation scores are also 
classified into stages of activation (1=believing that an active patient role is important; 
2=having the confidence and knowledge to take action; 3=taking action; 4=staying the 
course under stress); higher scores and higher stages of activation represent greater 
patient activation/engagement in their care.    
 Press-Ganey Questions. The 5 Press-Ganey questions assess family involvement 
in care, respect for choices, and support. Response options are presented on a 5 point 
scale, and range from 1 (very poor) to 5 (very good). Scores are summed, and raw scores 
are converted to a 0-100 point scale (Tackett, Tad-y, Rios, Kisuule, & Wright, 2013); 
higher scores indicate better outcomes.  
 Patient Assessment of Chronic Illness Care (PACIC). The PACIC is a valid, 
reliable instruments used to assess patient perceptions of the extent to which their health 
care is aligned with the chronic care model (Glasgow, Wagner, Schaefer, Mahoney, Reid, 
& Greene, 2005). The PACIC is comprised of 20 questions, which provide scores 
concordant with 5 sub-scales: patient activation (how much patient engagement is 
sought), delivery system design (how much information is provided to patients to aid in 
decision-making); goal setting/tailoring (how much patients were able to set health care 
goals with their providers); problem-solving/contextual (how much patient’s life 
circumstances are considered when forming treatment plans); follow-up/coordination 
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(care management and at-home follow-up). Questions ask that the patient to rate their 
care over the past 6 months, and are rated on a 5 point scale (1=no/never to 
5=yes/always). An overall mean is provided, along with mean scores for each sub-scale; 
higher scores indicate greater patient perceptions of care alignment with the chronic care 
model.   
 Combined Outcome Measure for Risk Communication and Treatment 
Decision Making Effectiveness (COMRADE)  
The COMRADE is a valid, reliable 20-item measure of patient’s perceptions of 
how much they are involved in the decision-making process when it comes to their care 
(e.g., shared decision-making) (Edwards et al., 2003). The scale provides scores for two 
sub-scales, which reflect the key elements of shared decision-making: risk 
communication (how well the benefits and risks of treatment options are communicated 
to the patient) and decision making effectiveness (how much patients are able to 
participate in making decisions about their treatment). Response options are presented on 
a 5 point scale, and range from 1 (strongly disagree) to 6 (strongly agree). Scores for the 
2 sub-scales are calculated based on an algorithm provided by the scale’s developers, and 
range from 0-100; higher scores represent greater patient perceptions of shared decision-
making.   
Provider Recommendations for Treatment  
Data on provider’s treatment recommendations (e.g., psychotherapy, 
pharmacology, CAM) were extracted from patient’s progress notes.  
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Patient Preferences for Treatment  
Assessment of patient preferences for treatment were made based on a 
comprehensive assessment of the content of progress notes across the course of 
treatment; an example of a patient preferences is if a patient tells their provider that they 
do not wish to participate in pharmacological treatment because they medication they are 
on gives them side-effects; the provider may either accommodate the patient’s preference 
(e.g., recommend an alternative, non-pharmacological treatment option) or recommend 
treatment that is not concordant with what the patient wants (e.g., insist the patient stays 
the course of the medication). 
Statistical Analyses 
Bivariate Comparisons  
To assess differences among Veterans with PTSD receiving IMH care to those 
receiving usual care, bivariate analyses were conducted for all variables (student’s t-tests 
were used in instances where the dependent variable was continuous, and chi-square tests 
in instances where the dependent variable was categorical) by group membership. 
Student’s t-tests assess the magnitude of the mean difference of a given variable between 
members of two independent groups; chi-square tests assess whether the proportion of 
individuals who fall into various categories of a given outcome variable are statistically 
significant across levels of an independent variable. Additionally, in cases where 
continuous outcome variables could be sensibly grouped together (e.g., select patient-
centered care, mental health care utilization, general health care utilization measures), 
Hotelling’s T2 tests were conducted in an effort to increase power.  
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 For all bivariate comparisons, patients in the two groups were compared on all 
demographic variables to highlight similarities and potential differences among groups; 
variables that showed significant differences were included in the multivariate logistic 
regression analysis as covariates, to control for potential confounding effects of those 
potential differences among groups on outcomes of interest. 
 Competing regression models were built based on significant bivariate 
associations, as well as commonly modeled variables as seen in the literature 
(significance will be based off of p < .05). Variables which produced significant chi-
square statistics were included in the model first. Consequently, individual variables that 
did not yield significant bivariate associations, but are typically included in such analyses 
for the population at hand, were also added to the model to create competing models. 
Multicolinearity among independent variables was assessed.  
Multivariate Logistic Regression Analyses  
To assess patient-centered care variables associated with receipt of integrative 
mental health care, a multivariate logistic regression was conducted. Logistic regression 
analysis is predominantly used to predict outcomes for a categorical dependent variable, 
from a set of multiple independent variables that can be continuous or categorical 
(Tabachnick & Fidell, 2007). Since the outcome variable in the current study is a 
dichotomous, categorical variable (type of mental health service received - integrative 
mental health care vs. usual care) and a group of predictor variables (both categorical and 
continuous variables), binary logistic regression was the best-suited analysis. Further, as 
the outcome variable is dichotomous and no a-priori hypotheses concerning the order of 
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importance of the predictor variables was established, a direct (as opposed to stepwise or 
sequential) logistic regression analysis was used (Tabachnick & Fidell, 2007).  
 Logistic regression analysis is based on the following assumptions: the 
relationship between continuous predictor variables and the transformed dependent 
variable is linear; independence of responses; adequate sample size to predictor variables 
ratio; adequate cell-frequencies for each independent variable included in the model (as 
well as the dependent variable); no outliers present in the data; that multicolinearity is not 
a problem pertaining to the group of independent variables (Tabachnick & Fidell, 2007).  
 Predictive utility of variables was assessed using the Wald chi-square statistic 
(Mendenhall & Sincich, 2011). In order to assess the fit of the regression model, the final 
model was compared to a null model (which does not include any predictor variables) 
(Tabachnick & Fidell, 2007). By subtracting the Log-likelihood (-2LL) value of the final 
model from that of the null model, a chi-square value assessing goodness of fit was 
obtained. The significance of this chi-square value is based on the number of predictor 
variables in the null model (1) minus the number of predictor variables in the model 
including the group of predictors (Tabachnick & Fidell, 2007).  If the final model yields a 
significant log-likelihood chi-square difference, the model increases the ability to predict 
the likelihood of each independent variable based on integrative mental health treatment 
receipt (Tabachnick & Fidell, 2007). 
 The logistic regression model provides odds ratios and 95% confidence intervals 
for each individual predictor variable. Odds-ratio values which exceed 1.0 are associated 
with increased odds of that variable for Veterans who received integrative mental health 
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treatment, and those which were less than 1.0 will be associated with decreased odds of 
that variable for Veterans who received integrative mental health treatment (Peng, Lee & 
Ingersoll, 2002). The analysis also generated 95% confidence intervals around the odds 
ratios; for each predictor variable, we can say with 95% confidence that the true 
population increase/decrease in the likelihood of that variable for Veterans who received 
integrative mental health treatment falls between the interval values.   
Mediation Analyses  
According to Baron and Kenny (1986), four relationships are necessary in order 
for mediation to be established. First, an association between the predictor variable and 
the outcome variable must be established [Path C]. Next, a relationship between the 
predictor variable and the mediating variable must be established [Path A]. Third, a 
relationship between the mediating variable and the outcome variable must be established 
[Path B] (Baron & Kenny, 1986). Once the first three paths are established, mediation is 
tested for. In order for any level of mediation to exist, the relationship between the 
mediator and the outcome variable must remain significant when the predictor variable is 
being controlled for. The mediating relationship is considered ‘full’ if, when the mediator 
is entered into the model, the predictor variable is no longer significant; alternatively, the 
mediating relationship is considered ‘partial’ if both the predictor and mediator are 
significant in the multiple regression model (Baron & Kenny, 1986).   
 For the current study, the hypothesis that the relationship between type of mental 
health treatment received (integrative mental health vs. usual mental health care) and 
receipt of adequate mental health treatment (9 or more mental health visit in the year 
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following treatment initiation) is mediated by patient perceptions of important patient-
centered care constructs (shared decision-making; patient activation) known to be 
associated with health services utilization, including mental health care services, was 
testing was tested using Hayes’ (2012) PROCESS Macro for SPSS (specifically, using 
the Model 4 template), which uses a bootstrapping approach to create confidence 
intervals for the indirect effects. Two meditational models were conducted; the 
established models consisted of the following variables: (1) group membership 
(integrative mental health vs. usual mental health care services received; predictor 
variable), patient perceptions of patient activation (mediator), and receipt of ‘adequate’ 
mental health services (outcome variable), and; (2) group membership (integrative mental 
health vs. usual mental health care services received; predictor variable), patient 
perceptions of shared decision-making (mediator), and receipt of ‘adequate’ mental 
health services (outcome variable).  
Moderated Mediation Analyses  
In some cases, a meditational effect can be present only for (or stronger in) one 
group/type of people vs. another; this type of relationship is referred to a moderated 
mediation. For the present study, moderated mediation was tested using Hayes’ (2012) 
PROCESS Macro for SPSS, which uses a bootstrapping approach to create confidence 
intervals for the indirect effects. Specifically, using the Model 14 template (please see 
Figure 1), the possibility that patient perceptions of shared decision-making mediate the 
relationship between receipt of IMH services and receipt of adequate mental health care 
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for PTSD only for patients with high patient activation (whereas no mediating 
relationship exists for those with low patient activation) was tested.  
Figure 1. Model 14 (Preacher, 2012) 
 
X 
[Treatment 
Type] 
Mi 
[Shared 
Decision-
Making] 
Y 
[Receipt of 
Adequate MH 
Treatment] 
V 
[Patient 
Activation] 
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CHAPTER SEVEN 
RESULTS 
As a disclaimer, prior to presenting the study results we would like to mention 
that while we realize the family-wise error issue present in this study, because the present 
research is somewhat exploratory we are using .05 as our type I error rate (e.g., to 
determine statistical significance). However, we will also be reporting results with p-
values less than .1, so as to avoid missing detection of possible benefits of the IMH 
program.  Such findings, however, should not be considered reliable without further 
replication(s), with data sets providing greater statistical power.    
Power Analyses 
Post-hoc power analyses were conducted to assess power associated with the 
administrative and survey data available for this project. Power analyses were conducted 
for variables with the lowest and highest effect sized (to establish the range of power for 
each data collection method) based on the procedure outlined by Cohen (1988): effect 
sizes were determined based on the results of the bivariate analyses, and in combination 
with the respective sample sizes, were used to determine power from look-up tables 
(Cohen, 1988).  
Administrative Data  
Of the variables compared between Veterans with PTSD who received IMH vs. 
UMH treatment using administrative data, power ranged from <26% - 94%. The variable 
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producing the lowest effect size (and thusly, the lowest power) was visits associated with 
suicide/self-injury (Cohen’s D=0.00; power=<26%), while prescription fills of 
psychotropic medications resulted in the highest power (Cohen’s D=0.28; power-94%). 
The high end of the range of power detected for the administrative data analyses was 
considered adequate (>80%), however, differences for some administrative data variables 
examined may be undetectable based on low power. Additionally, administrative data 
were collected for a sample of 234 Veterans; based on critical values, minimum 
necessary effect sizes to detect significant differences are: 0.13 for a chi-square test with 
1 degree of freedom, 0.16 for a chi-square test with 2 degrees of freedom, and 0.22 for a 
t-test.  
Survey Data  
Of the variables compared between Veterans with PTSD who received IMH vs. 
UMH treatment using survey data, power ranged from <12%->99.5%. The variable 
producing the lowest effect size (and thusly, the lowest power) was patient’s perceptions 
of their overall health care experience, as measured by the Global Practice Experience 
measure (effect size=0.01, power=<12%), while patient activation (Cohen’s D=-2.57, 
power=>99.5%) and shared-decision making (Cohen’s D=-0.49, power=81%) resulted in 
the highest power. The high end of the range of power detected for the survey data 
analyses surpassed the threshold for what is considered adequate power (>80%), 
however, differences for some survey variables examined may be undetectable based on 
low power. Additionally, survey data were collected for a sample of 61 Veterans; based 
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on critical values, minimum necessary effect sizes to detect significant differences are: 
0.25 for a chi-square test with 1 degree of freedom, and 0.44 for a t-test. 
Chart Review Data  
The chart review sample for the present study was determined based on an a-
priori power analysis. As a general rule, literature suggests that between 5 and 10 charts 
per variable of interest is the rule of thumb for deciding a chart review sample size 
(Gearing, Mian, Barber, & Ickowicz, 2006). Technically, 6 variables are being obtained 
from the chart review data collection piece of this project: pain severity, depression 
severity, PTSD symptom endorsement, PTSD symptom severity, provider’s treatment 
recommendations & discussion of patient’s preferences for treatment.  However, since 
symptom endorsement was examined separately for all 4 PTSD symptom clusters, the 
‘symptom endorsement’ variable is being considered as 4 separate variables. 
Accordingly, conducting chart reviews for 90 individuals provides sufficient power for 
the chart review data collection efforts of this project. Additionally, chart review data 
were collected for a sample of 90 Veterans; based on critical values, minimum necessary 
effect sizes to detect significant differences are: 0.21 for a chi-square test with 1 degree of 
freedom, 0.26 for a chi-square test with 2 degrees of freedom, and 0.35 for a t-test. 
Reliability: Scales Used to Measure PCC 
 For measurement scales for which we had item-level data (e.g., scales used to 
measure patient perceptions of PCC), we calculated the reliability among our sample 
(e.g., the Cohen’s α statistic) for each scale. All of the PCC scales were found to be 
highly reliable among our sample: (1) GPE, α =0.92; (2) CARE, α =0.99; (3) PAM, α 
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=0.91; (4) Press-Ganey questions, α =0.94; (5) PACIC, α =0.97; (6) VR-12, overall, α 
=0.87; VR-12, PCS, α =0.83; VR-12, MCS, α =0.74; (7) COMRADE, overall, α =0.98; 
COMRADE, RC, α =0.97; COMRADE, DME, α =0.90.  
Bivariate Comparisons 
Demographics, Chronic Health Conditions, and Comorbid Mental Health Diagnoses  
At baseline, Veterans comprising the IMH and UMH groups were extremely 
similar, with no significant differences noted across any demographic, chronic condition, 
or comorbid mental health condition diagnoses (see Table 2 below). There were a 
marginally greater proportion of men and individuals with bipolar disorder in the UMH 
group compared to the IMH group, however no statistically significant differences in 
demographics, physical or mental health conditions existed between Veterans comprising 
the IMH vs. UMH groups.   
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Table 2. Demographics, chronic conditions and comorbid mental health diagnoses for 
Veterans with PTSD who received IMH vs. usual mental health care (n=234) 
 Overall 
% 
(n=234) 
Usual 
Care 
(n=117) 
IMH  
(n=117) 
p-
value 
t- or 
chi-sq 
value 
df Effect 
Size* 
Demographics        
Male Gender 
(n=234) 
89.74 93.16 86.32 0.08 2.97 1 0.11 
Age (n=234)  
[Mean (range) SD] 
49.56 
(21.90-
87.43) 
15.55 
49.35 
(21.90-
87.43) 
16.09 
49.78 
(22.51-
78.11) 
15.05 
0.83 -0.21 232 -0.03 
Race (n=205)    0.13 4.02 2 0.14 
White 62.93 67.65 58.25     
Black 28.78 22.55 34.95     
Other
3 
8.29 9.80 6.80     
Ethnicity
1
 (n=219) 13.70 13.64 13.76 0.98 0.001 1 0.002 
Married
2
 (n=233) 57.51 52.59 62.39 0.13 2.29 1 0.10 
Service-Connected 
Disability % 
(n=234) 
   0.44 1.64 2 0.08 
0% 21.79 24.79 18.80     
1%-49% 23.08 20.51 25.64     
50%-100% 55.13 54.70 55.56     
Select Chronic Conditions 
(n=234) 
      
Heart Disease 28.21 28.21 28.21 1.00 0.00 1 0.00 
Cancer 9.83 7.69 11.97 0.27 1.21 1 0.07 
Chronic Lower 
Respiratory 
Disease 
20.94 23.08 18.80 0.42 0.65 1 0.05 
Stroke 5.98 5.98 5.98 1.00 0.00 1 0.00 
Diabetes 24.79 24.79 24.79 1.00 0.00 1 0.00 
Number of chronic 
conditions
3
 (count) 
[Mean (range) SD] 
0.90 
(0.00-
4.00) 
0.99 
0.90 
(0.00-
4.00) 
0.98 
0.90 
(0.00-
4.00) 
1.01 
1.00 0.00 232 0.00 
Multimorbidity
4 
24.36 26.50 22.22 0.45 0.58 1 0.05 
Select Mental Health 
Conditions (n=234) 
      
History of military 
sexual trauma  
9.40 8.55 10.26 0.65 0.20 1 0.03 
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Adjustment 
disorders  
8.97 9.40 8.55 0.82 0.05 1 0.01 
Anxiety disorders  43.16 41.88 44.44 0.69 0.16 1 0.03 
Impulse control 
disorders NEC 
(including 
pathological 
gambling)  
1.71 1.71 1.71 1.00 0.001 1 0.002 
Bipolar disorders  8.12 11.11 5.13 0.09 2.81 1 0.11 
Depressive 
disorders  
67.95 63.25 72.65 0.12 2.37 1 0.10 
Personality 
disorders  
3.42 4.27 2.56 0.47 0.52 1 0.05 
Schizophrenia & 
other psychotic  
disorders  
3.85 4.27 3.42 0.73 0.12 1 0.02 
Substance use 
disorders (alcohol 
and substance-
related disorders)  
20.09 19.66 20.51 0.87 0.03 1 0.01 
Suicide & 
intentional self-
inflicted  injury  
3.42 4.27 2.56 0.47 0.52 1 0.05 
1
Hispanic ethnicity presented
 
2
Reference group: Not Married 
3
Of the following chronic conditions: heart disease, cancer, chronic lower respiratory 
disease, stroke, diabetes 
4Defined as having ≥2 of the following chronic conditions: heart disease, cancer, chronic 
lower respiratory disease, stroke, diabetes 
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical 
variables 
 
Health Care Utilization  
Health care utilization variables were examine in the year following treatment 
initiation, and compared across UMH and IMH groups (see Table 3). As hypothesized, in 
regard to mental health care utilization, Veterans in the UMH group averaged 
significantly more prescription psychotropic medication fills in the year following 
treatment initiation than those in the IMH group. Contrary to hypotheses, no other 
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differences in ‘appropriate’ mental health utilization were observed between the UMH 
and IMH groups. While no statistically significant differences were observed in the 
proportion of Veterans who received adequate mental health care services between those 
who received IMH vs. UMH services, descriptively 22% of those in the IMH group 
received adequate mental health services, compared to about 18% of those in the UMH 
group.  
 Further, Hotelling’s T2 test examining differences in mental health utilization 
variables (outpatient visits related to mental health services, prescription psychotropic 
medication fills) between IMH and UMH groups simultaneously revealed marginally 
significant mean differences, Hotelling’s T2=5.34, F(2,231)=2.66, p=0.07, Mahalinobis 
Distance=0.30. (In order to reach significance, a Mahalinobis Distance of 0.36 is needed). 
These results corroborate that, overall, IMH services may catalyze change in mental 
health care utilization. 
 In terms of general health services use, as hypothesized, Veterans in the UMH 
group averaged a marginally lesser number of outpatient visits and specifically, primary 
care visits in the year following treatment initiation then those in the IMH group, 
indicating that IMH services may foster ‘appropriate’ health care utilization among 
Veterans with PTSD.  
 Hotelling’s T2 tests examining differences in general health care utilization 
variables (outpatient visits, ER visits, prescription medication fills) between IMH and 
UMH groups simultaneously, however, did not reveal significant mean differences, 
Hotelling’s T2=5.11, F(3,230)=1.69, p=0.17, Mahalinobis Distance=0.30. (In order to 
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reach significance, a Mahalinobis Distance of 0.36 is needed). These results indicate that, 
while receipt of IMH services may impact outpatient health care utilization, overall, 
receipt of these services may not impact general health care utilization trends when health 
care use is considered all together. 
Table 3. Health services utilization among Veterans with PTSD who received IMH vs. 
usual mental health care (n=234) 
 Overall % 
(n=234) 
Usual 
Care 
(n=117) 
IMH  
(n=117) 
p-
value 
t- or 
chi-sq 
value 
df Effect 
Size* 
Mental Health Services Utilization (n=234)    
Adequate mental 
health care 
utilization
1 
(%) 
20.09 17.95 22.22 0.41 0.67 1 0.05 
Outpatient visits 
related to mental 
health services 
[Mean (range) SD] 
5.64 
(0.00-
57.00) 
8.51 
4.89 
(0.00-
43.00) 
7.52 
6.38 
(0.00-
57.00) 
9.37 
0.18 -1.35 232 -0.18 
Prescription 
psychotropic 
medication fills 
[Mean (range) SD] 
4.12 
(0.00-
27.00) 
5.49 
4.86 
(0.00-
27.00) 
6.22 
3.37 
(0.00-
25.00) 
4.56 
0.04 2.10 232 0.27 
Visits Associated With Select Mental Health Conditions (n=234) [Mean (range) 
SD] 
 
Adjustment 
disorders  
0.11 
(0.00-
7.00) 
0.62 
0.14 
(0.00-
7.00) 
0.74 
0.08 
(0.00-
4.00) 
0.48 
0.46 0.73 232 0.10 
Anxiety disorders  0.62 
(0.00-
13.00) 
1.75 
0.61 
(0.00-
13.00) 
2.00 
0.62 
(0.00-
9.00) 
1.46 
0.94 -0.07 232 -0.01 
PTSD 8.39 
(0.00-
47.00) 
8.82 
7.96 
(0.00-
38.00) 
8.13 
8.83 
(0.00-
47.00) 
9.48 
0.45 -0.76 232 -0.10 
Impulse control 
disorders NEC 
(including 
pathological 
0.01 
(0.00-
1.00) 
0.11 
0.01 
(0.00-
1.00) 
0.09 
0.02 
(0.00-
1.00) 
0.09 
0.56 
 
-0.58 232 -0.11 
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gambling)  
Bipolar disorders  0.11 
(0.00-
7.00) 
0.67 
0.18 
(0.00-
7.00) 
0.88 
0.04 
(0.00-
4.00) 
0.38 
0.12 1.56 232 0.21 
Depressive 
disorders  
1.53 
(0.00-
18.00) 
3.08 
1.69 
(0.00-
18.00) 
3.63 
1.38 
(0.00-
16.00) 
2.41 
0.43 0.79 232 0.10 
Personality 
disorders  
0.01 
(0.00-
3.00) 
0.20 
0.03 
(0.00-
3.00) 
0.28 
0.00 
(0.00-
0.00) 
0.00 
0.32 1.00 232 0.15 
Schizophrenia & 
other psychotic  
disorders  
0.03 
(0.00-
4.00) 
0.30 
0.05 
(0.00-
4.00) 
0.41 
0.01 
(0.00-
1.00) 
0.09 
0.27 1.09 232 0.13 
Substance use 
disorders (alcohol 
and substance-
related disorders)  
0.26 
(0.00-
31.00) 
2.35 
0.16 
(0.00-
15.00) 
1.43 
0.35 
(0.00-
31.00) 
3.00 
0.54 -0.61 232 -0.08 
Suicide & 
intentional self-
inflicted  injury  
0.00 
(0.00-
0.00) 
0.00 
0.00 
(0.00-
0.00) 
0.00 
0.00 
(0.00-
0.00) 
0.00 
-- -- 232 0.00 
General Health Services Utilization (n=234)    
Inpatient 
discharges [Mean 
(range) SD] 
0.07 
(0.00-
6.00) 
0.47 
0.04 
(0.00-
1.00) 
0.20 
0.10 
(0.00-
6.00) 
0.64 
0.33 -0.97 232 -0.13 
Length of Stay  
[Mean (range) SD]  
0.50 
(0.00-
42.00) 
3.57 
0.24 
(0.00-
16.00) 
1.64 
0.74 
(0.00-
42.00) 
4.77 
0.29 
 
-1.06 232 -0.14 
Outpatient visits  
[Mean (range) SD] 
12.13 
(0.00-
68.00) 
14.28 
10.48 
(0.00-
68.00) 
12.98 
13.78 
(0.00-
61.00) 
15.36 
0.08 -1.77 232 -0.23 
Primary care visits 
[Mean (range) SD] 
1.50 
(0.00-
13.00) 
1.94 
1.26 
(0.00-
9.00) 
1.66 
1.74 
(0.00-
13.00) 
2.16 
0.06 -1.90 232 -0.25 
ER visits   0.24 0.27 0.22 0.61 0.51 232 0.08 
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[Mean (range) SD] (0.00-4.00 
0.64 
(0.00-
4.00) 
0.66 
(0.00-
3.00) 
0.62 
Prescription 
medication fills 
(general)    
[Mean (range) SD] 
16.19 
(0.00-
95.00) 
20.00 
17.03 
(0.00-
80.00) 
19.62 
15.36 
(0.00-
95.00) 
20.43 
0.53 0.64 232 0.08 
1
9 or more mental health treatment visits within 12 months of the patient’s index 
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical 
variables 
 
Physical Health  
Contrary to hypotheses, IMH and UMH groups did not differ on any of the proxy 
measures of physical health (visits with poor health indicators, self-reported physical 
health (VR-12) scores) (see Table 4). However, descriptively, average self-reported 
physical health scores were higher among Veterans in the IMH group compared to the 
UMH group (as hypothesized), though not significantly so. Overall, 87 Veterans had 1 
recorded pain score and 67 had multiple records of reported pain severity. When 
comparing Veterans who received IMH to those who received UMH, there were no 
differences in initially reported pain severity (3.80 vs. 3.33, p=0.4979); further, for those 
who had multiple recorded pain scores there were no differences in patient’s last recorded 
pain score (3.38 vs. 3.18, p=0.8092) and, contrary to hypotheses, no differences in the 
amount of change in pain among the two Veteran groups.  
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Table 4. Physical health indicators among Veterans with PTSD who received IMH vs. 
usual mental health care (n=234) 
 Overall % 
(n=234) 
IMH  
(n=117) 
Usual Care 
(n=117) 
p-
value 
t- or 
chi-sq 
value 
df Effect 
Size 
*** 
Hypertension
1
 
(n=234)  
29.49 33.33 25.64 0.20 1.66 1 0.08 
Diabetes
2
 (n=234) 3.85 3.42 4.27 0.73 0.12 1 0.02 
Hyperlipidemia
3
 
(n=234) 
16.67 18.80 14.53 0.38 0.77 1 0.06 
VR-12: PCS 
(n=60)
* 
[mean (range) SD] 
32.05 
(7.01-
59.90) 
12.41 
35.00 
(7.01-
59.90) 
13.12 
29.28 
(11.68-
55.06) 
11.21 
0.07 -1.82 5
8 
0.47 
Change in Pain 
Severity (n=67)** 
[mean (range) SD]  
0.54 
(-7.00-
10.00) 
3.77 
0.93 
(-7.00-
8.00) 
3.88 
0.24 
(-7.00-
10.00) 
3.70 
0.46 -0.74 6
5 
0.18 
1Blood pressure: diastolic blood pressure ≥ 90 and systolic blood pressure ≥ 140 indicates 
poor disease control; the number of visits where an indication of poor condition 
management was recoded is presented for each time period 
2Hemoglobin A1C: HbA1c ≥9 indicates poor disease management; the number of visits 
where an indication of poor condition management was recoded is presented for each 
time period 
3Low Density Lipids (LDL): LDL ≥ 130 indicates poor disease control; the number of 
visits where an indication of poor condition management was recoded is presented for 
each time period 
*Obtained via CEPEP survey 
**Obtained via medical chart review abstraction 
***Effect size measures reflect Cohen’s D for continuous variables and Phi for 
categorical variables 
 
Depression Symptom Severity, and Self-Reported Mental Health Scores  
Contrary to hypotheses, there were no significant differences in self-reported 
mental health scores between Veterans in the IMH group compared to the UMH group 
(see Table 5). Overall, 29 Veterans had 1 recorded PHQ-9 score, and 9 had multiple 
records of reported depression severity. When comparing Veterans who received IMH to 
those who received UMH, there were no differences in initially reported depression 
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severity (16.69 vs. 14.56, p=0.4145); further, for those who had multiple recorded 
depression scores there were no differences in patient’s last recorded depression score 
(17.60 vs. 14.75, p=0.6149) and, contrary to hypotheses, no differences in the amount of 
change in depression among the two Veteran groups. 
Table 5. Self-reported mental health status and depression severity among Veterans with 
PTSD who received IMH vs. usual mental health care (n=61) 
 Overall % 
(n=61) 
Usual 
Care 
(n=31) 
IMH  
(n=30) 
p-
value 
t- or 
chi-
sq 
value 
df Effect 
Size*** 
VR-12: MCS 
(n=60)* 
[mean (range) SD] 
37.53 
(15.06-
63.38) 
12.91 
35.86 
(15.06-
63.38) 
13.04 
39.31 
(17.80-
59.72) 
12.76 
0.30 -1.04 58 -0.27 
Change in 
Depression 
Severity; PHQ-9 
Score (n=9)** 
[Mean (range) SD]  
0.56 
(-7.00-
7.00) 
4.03 
-0.20 
(-7.00-
7.00) 
5.26 
1.50 
(-1.00-
4.00) 
2.08 
0.57 0.60 7 -0.43 
*Obtained via CEPEP survey 
**Obtained via medical chart review abstraction 
***Effect size measures reflect Cohen’s D for continuous variables and Phi for 
categorical variables 
 
PTSD Symptom Endorsement and Symptom Severity  
Overall, 39 Veterans had 1 recorded PCL score, and 16 had multiple records of 
reported PTSD symptom severity. When comparing Veterans who received IMH to those 
who received UMH (please see Table 6), there were no differences in initially reported 
PTSD symptom severity or last recorded PCL score (51.43 vs. 60.78, p=0.1957); contrary 
to hypotheses, there were no differences in the amount of change in PTSD symptom 
severity among the two Veteran groups. Contrary to what we expected, however, visit-
level data indicates that a greater proportion of Veterans receiving IMH (vs. UMH) 
79 
 
 
reported experiencing intrusion symptoms, and symptoms related to alterations in arousal 
and reactivity, during primary care or mental health encounters with VA providers.  
Table 6. PTSD symptom endorsement and severity among Veterans with PTSD who 
received IMH vs. usual mental health care (n=90) 
 Overall 
% (n=90) 
Usual 
Care  
(n=45) 
IMH  
(n=45) 
p-
value 
t- or 
chi-
sq 
value 
df Effect 
Size* 
Symptom Severity        
At least 1 PCL score 
documented % 
(n=90) 
43.33 46.67 40.00 0.52 0.41 1 0.07 
Initial PCL Score 
[Mean (range) SD] 
(n=39) 
60.28 
(24.00-
83.00) 
13.93 
57.81 
(24.00-
74.00) 
16.38 
63.17 
(43.00-
83.00) 
10.08 
0.24 -1.20 37 -0.39 
Multiple PCL scores 
documented % 
(n=90) 
17.78 20.00 15.56 0.58 0.30 1 0.06 
Change in PCL 
Score [Mean (range) 
SD] (n=16) 
10.75 
(-5.00-
34.00) 
11.58 
7.67 
(-3.00-
19.00) 
7.28 
14.71 
(-5.00-
34.00) 
15.24 
0.24 -1.23 14 -0.59 
Change in PCL 
Score % (n=39) 
   0.88 0.25 2 0.05 
Only 1 Documented 
Score (%) 
71.79 71.43 72.22     
Treatment 
Responsive 
Improvement in PCL 
Score (%) 
7.69 9.52 5.56     
Clinically Significant 
Improvement in PCL 
Score (%) 
20.51 19.05 22.22     
Symptom 
Endorsement (%) 
(n=2799) 
       
Intrusion Symptoms    0.05 5.82 2 0.05 
Symptom(s) present 15.18 14.68 15.76     
Not Mentioned 84.03 84.17 83.86     
No symptoms 0.79 1.15 0.38     
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Avoidance 
Symptoms 
   0.14 3.96 2 0.04 
Symptom(s) present 7.72 8.25 7.12     
Not Mentioned 91.46 90.66 92.35     
No symptoms 0.82 1.08 0.53     
Negative Alterations 
in Cognitions and 
Mood Symptoms 
   0.14 3.92 2 0.04 
Symptom(s) present 6.43 6.22 6.67     
Not Mentioned 93.18 93.17 93.18     
No symptoms 0.39 0.61 0.15     
Alterations in 
Arousal and 
Reactivity 
Symptoms 
   0.001 13.39 2 0.07 
Symptom(s) present 21.22 19.42 23.26     
Not Mentioned 78.21 79.63 76.59     
No symptoms 0.57 0.95 0.15     
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical 
variables 
 
Patient Perceptions of Patient-Centered Care Constructs (Table 7) 
In line with hypotheses, patient perceptions of patient activation and the decision-
making effectiveness component of shared decision-making were marginally lower, on 
average, among Veterans receiving UMH compared to those receiving IMH (see Table 
7). Additionally, a greater proportion of Veterans receiving UMH were in the lowest 
stage of activation, as compared to those receiving IMH. No other differences in patient 
perceptions of PCC constructs were noted across the two groups.  
 Hotelling’s T2 tests examining differences in patient-centered care variables 
(patient activation, shared decision-making, consultation and relational empathy, 
perceptions of patient activation in terms of chronic illness care delivery, perceptions of 
family involvement in care, respect for choices, and support) between IMH and UMH 
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groups simultaneously, however, did not reveal significant mean differences, Hotelling’s 
T
2
=8.63, F(6,39)=1.27, p=0.29, Mahalinobis Distance=0.87. (In order to reach 
significance, a Mahalinobis Distance of 1.08 is needed). These results indicate that, while 
receipt of IMH services may impact patient’s perceptions of shared decision-making and 
patient reported engagement in their health care (i.e., patient activation), overall, receipt 
of these services may not impact general trends in patient’s perceptions of the patient-
centeredness of their health care, when patient-centered care variables are considered all 
together. 
Table 7. Perceptions of patient-centered care among Veterans with PTSD who received 
IMH vs. usual mental health care (n=61) 
 Overall 
% 
(n=61) 
Usual Care 
(n=31) 
IMH  
(n=30) 
p-
value 
t- or 
chi-
sq 
value 
df Effect 
Size* 
Patient Perceptions of Patient-Centered Care Constructs    
PAM  (n=57)  
[mean (range) SD]  
56.37 
(0.00-
100.00) 
22.44 
51.18 
(0.00-
100.00) 
4.20 
61.74 
(0.00-
100.00) 
4.03 
0.08 -1.81 55 -2.57 
PAM Stages (n=57)        
Stage 1 (%) 31.58 44.83 17.86 0.03 4.80 1 0.29 
Stage 2 (%) 12.28 13.79 10.71 0.72 0.13 1 0.05 
Stage 3 (%) 24.56 17.24 32.14 0.19 1.71 1 0.17 
Stage 4 (%) 31.58 24.14 39.29 0.22 1.51 1 0.16 
COMRADE        
Risk Communication 
(n=51)  
[mean (range) SD] 
56.46 
(13.48-
86.97) 
19.56 
53.78 
(13.48-
86.97) 
21.06 
59.03 
(21.82-
80.76) 
18.04 
0.34 -0.96 49 -0.27 
Decision-Making 
Effectiveness (n=51) 
[mean (range) SD] 
59.63 
(19.56-
86.14) 
20.17 
54.69 
(19.56-
81.14) 
23.75 
64.39 
(20.73-
80.31) 
14.98 
0.09 -1.75 49 -0.49 
CARE (n=59) 
[mean (range) SD] 
37.58 
(10.00-
36.15 
(10.00-
39.07 
(10.00-
0.40 -0.85 57 -0.22 
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50.00) 
13.22 
50.00) 
14.01 
50.00) 
12.41 
PACIC (n=58) 
[mean (range) SD] 
3.02 
(1.00-
5.00) 
1.31 
2.91 
(1.05-5.00) 
1.38 
3.14 
(1.00-
5.00) 
1.24 
0.51 -0.67 56 -0.18 
Patient Activation 
(n=58) 
3.07 
(1.00-
5.00) 
1.48 
3.02 
(1.00-5.00) 
1.62 
3.12 
(1.00-
5.00) 
1.34 
0.81 -0.25 56 -0.07 
Delivery Systems 
Design (n=58) 
3.32 
(1.00-
5.00) 
1.40 
3.16 
(1.00-5.00) 
1.47 
3.50 
(1.00-
5.00) 
1.33 
0.36 -0.92 56 -0.24 
Goal 
Setting/Tailoring 
(n=58) 
3.05 
(1.00-
5.00) 
1.40 
2.85 
(1.00-5.00) 
1.47 
3.27 
(1.00-
5.00) 
1.30 
0.26 -1.14 56 -0.30 
Problem 
Solving/Contextual 
Counseling (n=58) 
3.16 
(1.00-
5.00) 
1.51 
3.03 
(1.00-5.00) 
1.53 
3.29 
(1.00-
5.00) 
1.50 
0.53 -0.63 56 -0.17 
Follow-Up/Care 
Coordination (n=58) 
2.65 
(1.00-
5.00) 
1.36 
2.62 
(1.00-5.00) 
1.43 
2.68 
(1.00-
5.00) 
1.31 
0.86 -0.18 56 -0.04 
Press-Ganey (n=54) 
[mean (range) SD] 
2.65 
(0.00-
100.00) 
26.93 
62.93 
(0.00-
100.00) 
28.02 
69.80 
(20.00-
100.00) 
25.68 
0.35 -0.93 52 -0.26 
GPE (n=51)    0.94 0.01 1 0.01 
Successful 25.49 25.93 25.00     
Not Successful 74.51 74.07 75.00     
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical 
variables 
 
Provider Recommendations for Treatment (see Table 8)  
Overall, visit-level data indicates that recommendations for mental health 
treatment were made during a greater proportion of IMH visits (vs. UMH visits). 
Additionally, while pharmacology was recommended during a lesser proportion of IMH 
83 
 
 
visits, CAM treatment modalities were recommended during a greater proportion of IMH 
visits.  
Table 8. Provider recommendations for treatment for Veterans with PTSD who received 
IMH vs. usual mental health care (n=2109) 
 Overall 
% 
(n=90) 
IMH  
(n=45) 
Usual 
Care  
(n=45) 
p-value t- or 
chi-
sq 
value 
df Effect 
Size* 
Provider Recommendations for Treatment    
Note Included 
Recommendations 
for Treatment 
(n=2799) 
   <0.0001 33.81 1 0.11 
Yes 39.16 44.85 34.10     
No 60.84 57.91 62.53     
If yes, the 
recommendation was 
for: (n=1096) 
       
Psychotherapy 80.75 80.07 81.55 0.54 0.38 1 0.02 
Pharmacology 51.55 47.30 56.55 0.002 9.33 1 0.09 
CAM (i.e., yoga, 
MBSR, etc.) 
7.21 9.97 3.97 0.0001 14.64 1 0.12 
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical 
variables 
 
Patient Preferences for Treatment (see Table 9)  
Visit-level data indicates that patient preferences for mental health treatment were 
discussed during a greater proportion of IMH visits than UMH visits. 
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Table 9. Patient preferences for treatment among Veterans with PTSD who received IMH 
vs. usual mental health care (n=2109) 
 Overall 
% (n=90) 
Usual 
Care  
(n=45) 
IMH  
(n=45) 
p-
value 
t- or 
chi-
sq 
value 
df Effect 
Size* 
Note Included 
Communication 
about the Patient’s 
Preference for Mental 
Health Treatment 
(n=2799) [visit-level 
data] 
   0.001 10.17 1 0.06 
Yes 19.22 16.98 21.74     
No 80.78 83.02 78.26     
Patient’s Preferences 
for Treatment Were 
Met, Overall (n=90) 
[individual level 
data] 
   0.84 0.34 2 0.06 
Yes 84.44 82.22 86.67     
No 7.78 8.89 6.67     
Treatment 
Preferences Not 
Mentioned 
7.78 8.89 6.67     
*Effect size measures reflect Cohen’s D for continuous variables and Phi for categorical 
variables 
 
Multivariate Logistic Regression: Factors Associated with Receipt of Integrative 
Mental Health Treatment – Dependent Variable: IMH receipt [reference: UMH 
receipt] 
 We compared a regression model consisting of patient perceptions of patient-
centered care constructs which produced significant/marginally significant differences in 
the bivariate comparisons in tandem with other patient-centered care constructs (as we 
hypothesized that higher patient perceptions of each patient-centered construct would be 
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independently associated with receiving IMH services) to a model using only predictor 
variables which produced significant/marginally significant differences in the bivariate 
comparisons [patient activation; shared decision-making]. Predictive utility of variables 
was assessed using the Wald chi-square statistic (Mendenhall & Sincich, 2011); the 
variables with significant Wald results were associated with receipt of IMH services.    
 In order to assess the fit of our regression model, we compared the final model to 
a null model, which did not include any predictor variables (Tabachnick & Fidell, 2007). 
By subtracting the Log-likelihood (-2LL) value of the final model from that of the null 
model, we obtained a chi-square value assessing goodness of fit. The significance of this 
chi-square value was based on the number of predictor variables in the null model (1) 
minus the number of predictor variables in the model including our group of predictors 
(Tabachnick & Fidell, 2007).  
 The first model created contained all patient-centered care constructs assessed 
with the CEPEP survey. Multicolinearity was assessed using the variance inflation factor 
(VIF) index; the rule of thumb for assessing multicolinerity using the VIF is as low as 
values >4 - to values >10 - indicate high multicolinearity (O’Brien, 2007); none of the 
patient-centered care constructs had to be removed due to mutlicolinearity. The model 
containing all patient-centered care constructs produced a -2LL value of -24.46, with 7 
degrees of freedom (compared to the null model produced a -2LL value of -162.20, with 
1 degree of freedom), and an R-squared of 0.12. The log-likelihood difference between 
this initial model and the null model was 137.7, with 6 degrees of freedom, which is a 
significant chi-square value, p<.05. 
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 A competing model was then created, which contained only patient activation and 
shared decision-making (the patient centered care constructs which were marginally 
different between IMH and UMH groups in the bivariate comparisons). This model 
produced a -2LL value of -31.10, with 2 degrees of freedom (compared to the null model 
produced a -2LL value of -162.20, with 1 degree of freedom), and an R-squared of 0.08. 
The log-likelihood difference between this initial model and the null model was 131.10, 
with 1 degree of freedom, which is a significant chi-square value, p<.05.  
 Since both models displayed a significant increase in fit over the null model, to pit 
them against one another we subtracted the -2LL values for the model containing only 
patient activation and shared decision-making to the model containing all of the patient-
centered care constructs; based on (7 – 2 = 5) degrees of freedom, our log-likelihood 
difference of: 31.10 – 24.46 = 6.64, which is not significant at p<0.05. While this non-
significant -2LL test indicates that both models are of relatively similar fit, the model 
containing only the variables which produced significant bivariate associations was 
selected this as the final model as it was the more parsimonious model.  
 The logistic regression model provided us with odds ratios and 95% confidence 
intervals for each individual predictor variable. Odds-ratio values which exceeded 1.0 
were associated with increased odds of having received an adequate amount of 
information, and those which were less than 1.0 were associated with decreased odds 
(Peng, Lee & Ingersoll, 2002). The analysis also generated 95% confidence intervals 
around the odds ratios; for each predictor variable, we are 95% confident that the true 
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population increase/decrease in the likelihood for having received IMH services falls 
between the interval values.  
 While accounting for approximately 8% of the variance between receipt of IMH 
compared to UMH treatment, the final model did not identify either of the included 
patient-centered care constructs as being independently associated with receipt of IMH 
services (see Table 10).  
Table 10. Logistic regression analysis: patient-centered care constructs independently 
associated with receipt of IMH treatment (n=49)  
 
 
Odds 
Ratio 
95% Wald 
Confidence Limits 
p-value 
Patient Activation [PAM]  2.86 0.76 10.78 0.12 
Shared Decision-Making [COMRADE]     
Decision-Making Effectiveness 1.02 0.98 1.05 0.34 
*R-squared: 0.08 
Mediation Analyses 
Patient Activation As A Mediator Between IMH vs. UMH Treatment and Receipt of 
Adequate Mental Health Care  
The first mediation model conducted examined whether patient activation 
mediated the relationship between receipt of IMH treatment and receipt of adequate 
mental health care (please see Figure 2). In this model, we examined whether group 
membership (integrative mental health vs. usual mental health care services received) 
predicted patient activation, whether patient activation predicted receipt of ‘adequate’ 
mental health services, and whether the relationship between group membership and 
receipt of ‘adequate’ mental health services was significantly reduced when we 
controlled for patient activation (Baron & Kenny, 1986).  
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 Figure 2 contains a depiction of the results from this mediational analysis. As 
predicted, Veterans who received IMH treatment reported (marginally) higher levels of 
patient activation (path a was marginally significant: unstandardized β=10.56, SE=5.83, 
p=0.08; standardized β=0.24, SE=0.13, p=0.08). However, being a Veteran with higher 
patient activation was not significantly related to receiving adequate mental health 
treatment (path b was not significant, unstandardized β=0.004, SE=0.01, p=0.79; 
standardized β=0.08, SE=0.31, p=0.79). Further, group membership (receipt of IMH vs. 
UMH treatment) was not predictive of receiving adequate mental health care 
(unstandardized β=0.19, SE=0.62, p=0.76; standardized β=0.10, SE=0.31, p=0.76). 
Finally, after taking the relationship between group membership and patient activation 
into account, the direct path between group membership and receipt of adequate mental 
health care (path c) was (still) not significant (unstandardized β=0.19, SE=0.62, p=0.76; 
standardized β=0.10, SE=0.31, p=0.76).  
 Despite one of the assumptions underlying mediation was not met (e.g., 
insignificant path b), we tested the significance of the indirect path (and thus tested for 
mediation). The combined indirect paths (e.g. group membership to patient activation and 
patient activation to receipt of adequate mental health treatment) were not significant, 
unstandardized β=0.04, SE=0.20, CI95%=-0.34-0.59; standardized β=0.02, SE=0.10, 
CI95%=-0.15-0.27. Therefore, results indicate that the relationship between group 
membership and receipt of adequate mental health care is not mediated by patient 
activation.  
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Figure 2. Mediational Model: Patient Activation 
 
 
 
 
 
 
 
 
 
 
 
            
 
    [*=marginally significant at p<.10; unstandardized Betas are shown]       
Shared Decision-Making As A Mediator Between IMH vs. UMH Treatment and 
Receipt of Adequate Mental Health Care 
          The second mediation model conducted examined whether shared decision-making 
mediated the relationship between receipt of IMH treatment and receipt of adequate 
mental health care (please see Figure 3). In this model, we examined whether group 
membership (integrative mental health vs. usual mental health care services received) 
predicted shared decision-making, whether shared decision-making predicted receipt of 
‘adequate’ mental health services, and whether the relationship between group 
membership and receipt of ‘adequate’ mental health services was significantly reduced 
when we controlled for shared decision-making (Baron & Kenny, 1986). 
 Figure 3 contains a depiction of the results from this mediational analysis. In this 
model, we examined whether group membership (integrative mental health vs. usual 
mental health care services received) predicted patient’s perceptions of shared medical 
Group 
Membership 
(IMH vs. 
UMH) 
Patient 
Activation 
Receipt of 
‘Adequate’ 
MH 
Treatment 
A = 10.56* 
C’ = .04 
B = 0.004 
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decision-making, whether patient’s perceptions of shared medical decision-making 
predicted receipt of ‘adequate’ mental health services, and whether the relationship 
between group membership and receipt of ‘adequate’ mental health services was 
significantly reduced when we controlled for patient’s perceptions of shared medical 
decision-making (Baron & Kenny, 1986).  
 As predicted, Veterans who received IMH treatment reported (marginally) higher 
perceptions of shared medical decision-making (path a was marginally significant: 
unstandardized β=9.70, SE=5.54, p=0.09; standardized β=0.24, SE=0.14, p0.09) (Figure 
4). However, being a Veteran with a higher perception of shared medical decision-
making was not significantly related to receiving adequate mental health treatment (path 
b was not significant; unstandardized β=0.01, SE=0.02 p=0.46; standardized β=0.27, 
SE=0.36, p=0.46). Further, group membership (receipt of IMH vs. UMH treatment) was 
not predictive of receiving adequate mental health care (unstandardized β=-0.17, 
SE=0.68, p=0.81; standardized β=-0.08, SE=0.34, p=0.81). Finally, after taking the 
relationship between group membership and patient’s perceptions of shared medical 
decision-making into account, the direct path between group membership and receipt of 
adequate mental health care (path c) was (still) not significant (unstandardized β=-0.17, 
SE=0.68, p=0.81; standardized β=-0.08, SE=0.34, p=0.81).  
 Despite one of the assumptions underlying mediation was not met (e.g., 
insignificant path b), we tested the significance of the indirect path (and thus tested for 
mediation). The combined indirect paths (e.g. group membership to perceptions of shared 
medical decision-making and perceptions of shared medical decision-making to receipt of 
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adequate mental health treatment) were not significant, unstandardized β=0.13, SE=0.40, 
CI95%=-0.21-1.15; standardized β=0.07, SE=0.18, CI95%=-0.12-0.59. Therefore, results 
indicate that the relationship between group membership and receipt of adequate mental 
health care is not mediated by patient’s perceptions of shared medical decision-making.  
Figure 3. Mediational Model: Shared Decision-Making 
 
 
 
 
 
 
 
 
 
 
 
 
[*=marginally significant at p<.10; unstandardized Betas are shown]       
Moderated Mediation Analyses 
 The impact of shared medical decision-making on the relationship between 
treatment group and receipt of adequate mental health treatment was much larger for 
Veterans with high patient activation (unstandardized β=0.4527; CI: -0.2768 - 5.8966; 
standardized β=0.23, CI: -0.17 – 2.64) than those with low patient activation 
(unstandardized β=0.0510; CI: -2.0974 - 1.7274; standardized β=0.03, CI: -1.20 – 0.75), 
however, as neither of these effects were significant, a true difference of zero cannot be 
ruled out. Additionally, the index of moderated mediation indicates that the effects of 
Group 
Membership 
(IMH vs. 
UMH) 
Shared 
Decision-
Making 
Receipt of 
‘Adequate’ 
MH 
Treatment 
A = 9.70* 
C’ = .13 
B = 0.01 
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shared medical decision-making on the relationship between treatment group and receipt 
of adequate mental health treatment do not significantly differ between Veterans with 
high vs. low patient activation, however, descriptively the effects are going in the 
hypothesized direction.  
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CHAPTER EIGHT 
DISCUSSION 
Collectively, the results of this project indicate that, among Veterans with PTSD 
receiving VA health care, IMH treatment receipt is associated with: increased outpatient 
and primary care visits; decreased psychotropic medication use; increased 
recommendations for CAM treatment modalities and decreased recommendations for 
pharmacological treatment; discussion of patient preferences for mental health treatment 
during a greater number of VA primary care and mental health encounters; better patient 
perceptions of physical health status; greater patient-reported patient activation (e.g., 
engagement in health care), and; better patient perceptions of shared medical decision-
making. Specifically: 
Health Care Utilization and Provider Recommendations for Treatment 
 Previous research has found that, among Veterans with mental health concerns, 
mental health treatment receipt in an IMH setting may foster more appropriate health care 
utilization; specifically, increased primary care and specialty medical care visits (Engel, 
Malta, Davies, & Baker, 2011) and decreased preventable hospitalizations (Pirraglia, 
Kilbourne, Lai, Friedmann, & O’Toole, 2011). In line with these findings, of the 
Veterans with PTSD in our cohort, those who were in the IMH group had a marginally 
greater number of outpatient visits in general, as well as primary care visits specifically, 
in the year following treatment initiation.  
94 
 
 
 We did not, however, find differences in hospitalizations, ER visits, or overall 
number of prescription medications filled between Veterans receiving IMH services as 
compared to those receiving UMH treatment. Though one previous study has also failed 
to observe decreases in ER use among Veterans receiving IMH treatment (Engel, Malta, 
Davies, & Baker, 2011), these null findings were not entirely aligned with the literature 
or hypotheses.  
 Further, contrary to hypotheses, we also did not find differences in the proportion 
of Veterans who received adequate mental health treatment in the year following 
treatment initiation, nor did we detect differences in the average number of mental health 
specialty care visits or the average number of visits for any specific mental health 
diagnoses (including PTSD), between our IMH and UMH groups. Similarly, one recent 
study found that Veterans with PTSD who received a psychotherapy referral from a 
primary care provider were less likely to initiate treatment as compared to those who 
were referred from a specialty mental health provider (Keller & Tuerk, 2015). These 
differences in appropriate mental health care use were expected, however, as several 
other previous studies have reported improved mental health care utilization among 
Veterans with mental health concerns, specifically, improved mental health care 
continuation (Bohnert, Pfeiffer, Szymanski, & McCarthy, 2013), treatment retention in 
mental health care (Tsan, Zeber, Stock, Sun, & Copeland, 2012), and increased utilization 
of specialty mental health services (Wray, Szymanski, Kearney, & McCarthy, 2012).  
 It may be the case that inadequate power is behind the lack of differences detected 
in this project as compared to previous research, as post-hoc power analyses indicated a 
95 
 
 
particularly low likelihood of being able to detect differences in some utilization 
variables (e.g., adequate mental health treatment; visits associated with specific mental 
health diagnoses) even if differences were to be present. However, the implications of the 
results of our moderated mediation analyses (as described below) may also be at play, in 
which patient’s level of activation (i.e., engagement in health care) may be the driving 
force between IMH treatment receipt and mental health care utilization. 
 We did find that Veterans in the IMH group filled less psychotropic prescription 
medications, on average, then those in the UMH group in the year following treatment 
initiation. These findings are inconsistent with some literature, which ascertains that IMH 
treatment increases adherence to pharmacological treatment in other cohorts of Veterans 
with mental health concerns (e.g., depression) (Fortney et al., 2011). However, various 
complementary and alternative medicine (CAM) (e.g., meditation, mindfulness and 
relaxation practices, yoga) treatment options are available for Veterans with PTSD 
throughout the VA health care system (Libby, Pilver & Desai, 2012), and Veterans with 
PTSD may benefit greatly from CAM modalities (Smeeding et al., 2010).  
 However, the results of the chart reviews conducted for the present study indicate 
that, while treatment recommendations via psychotherapy may be similar between IMH 
and UMH groups, CAM treatment modalities may be recommended as treatment options 
more often in visits among Veterans receiving IMH treatment, while pharmacology may 
be recommended for treatment more often in visits among Veterans receiving UMH care. 
This is in line with literature finding that Veterans with PTSD receiving their care in 
specialty mental health clinics (vs. Veterans receiving integrated mental health care) 
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filled a greater number of psychotropic prescriptions (Vojvoda, Stefanovics, & 
Rosenheck, 2014), and may be driving the presently observed differences in psychotropic 
medication use between our IMH and UMH groups. 
 Since both IMH treatment delivery and offering CAM treatment modalities are 
aspects of mental health care that are highlighted in efforts to create a patient-centered 
care environment, it is not surprising that our results indicate that the two are related. 
Further, literature indicates that Veterans who reported using CAM treatment modalities 
were more likely to have PTSD than those who are not CAM users (Baldwin, Long, 
Kroesen, Brooks & Belle, 2002), and that CAM use among persons with PTSD is high, 
both along-side and instead of traditional treatment options (Libby, Pilver & Desai, 
2013). This evidence indicates that some Veterans with PTSD may prefer to utilize CAM 
treatment modalities over traditional PTSD treatment options. Accordingly, it may be the 
case that providers delivering IMH treatment may be offering treatment modalities 
alternative to medication for Veterans with PTSD in an effort to provide more patient-
centered options for mental health care, and as such, driving down the rates of 
pharmacology use among these patients.    
Patient Preferences for Treatment 
  In line with the notion that CAM treatment modalities may be preferential 
treatment options among persons with PTSD, and that CAM treatment modalities may be 
recommended as treatment options more often in visits among Veterans receiving IMH 
treatment, our visit-level data indicates that patient preferences for treatment were 
discussed during a greater proportion of IMH visits than UMH visits as well. This is not 
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surprising, as the consideration of patient preferences for treatment in treatment planning 
and recommendations is an integral part of patient-centered care provision (IOM, 2001; 
Barry & Edgman-Levitan, 2012) and a goal of the VA (VHA, 2014).  
 However, our visit-level chart review data also indicated that less than a quarter of 
notes from primary care and mental health visits overall documented patient’s 
preferences for mental health treatment; while a conversation about patient’s preferences 
may not have been appropriate or natural during all visits reviewed as part of the data 
collection process for this piece of the current study, this finding suggests that there may 
be some room for improvement in discussing and considering patient’s preferences for 
treatment among Veterans with PTSD during primary care and mental health visits. 
 There is some evidence that, when documenting details of mental health visits for 
Veterans with PTSD, VA mental health care providers record information that they 
believe is vital for them to remember in order to provide appropriate care for the patient, 
while omitting details that they do not believe are vital for are improvement or may 
actually hinder care provision (Tuepker et al., 2015). As such, improvement efforts 
geared toward educating providers about the importance of discussing and considering 
patient’s preference for treatment, and using that information to drive future treatment 
and care planning efforts, may be warranted.  
 Furthermore, alignment of treatment with patient preferences for treatment has 
been linked to increased engagement in care (Kwan, Dimidjian, & Rizvi, 2010) and 
treatment adherence (Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008; Thompson, 
& McCabe, 2012). It is therefore not surprising that in the present study, results indicate 
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that there is a link between IMH treatment and both increased patient engagement (as 
expanded upon below) and discussion of patient preferences for mental health care. 
Alternatively, it may be the case that increased patient engagement empowers patients to 
open up during visits with their VA providers and make their preferences for treatment 
know, and that the differences observed in discussion of patient preferences for care were 
patient driven rather than provider driven. In any case, overall, our patient-level data 
suggest that the VA is doing very well at meeting patient preferences for treatment 
overall, with no person-level differences observed between Veterans receiving IMH 
compared to UMH in terms of the proportion of Veterans who had their mental health 
preferences met over the course of their care in the year following treatment initiation. 
Physical Health and Pain 
 The receipt of IMH treatment has been reported to be associated with 
improvements in important health outcomes such as glycated hemoglobin A1c, 
cholesterol, and blood-pressure levels in patients with chronic conditions (e.g., diabetes, 
coronary heart disease (CHD) or both) and comorbid depression (Katon et al., 2010). 
However, in the current project no differences were observed in proxy indicators of 
physical health (e.g., the number of visits with poor health indicators for chronic 
condition management of diabetes, hypertension, or hyperlipidemia) between Veterans 
receiving IMH vs. UMH care. Additionally, IMH treatment receipt has been associated 
with decreased pain among Veteran cohorts (Dobscha et al., 2009), but our findings did 
not suggest differences in pain (baseline, last recorded, or pain difference scores) among 
Veterans with PTSD who receive IMH compared to those who receive UMH care. 
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 Interestingly, though, Veterans in the IMH group reported marginally higher 
physical health scores (as measured by the VR-12), on average, than those in the UMH 
group; taken together, these findings suggest that aspects of physical health which may 
not be captured via proxy measures of physical health may be improved in patients who 
received IMH treatment over those who received UMH treatment. Additional research 
may be warranted to examine the impact of IMH treatment receipt on a more 
comprehensive gamut of factors related to physical health that may impact patient’s 
perceptions of their physical health status, namely factors which may be most important 
to patients regarding their physical health and functioning.   
Mental Health Symptoms: Depression Symptom Severity, Self-Reported Mental 
Health Scores, PTSD Symptom Endorsement and PTSD Symptom Severity 
 Prior literature has indicated that IMH treatment receipt may be effective in 
reducing depression severity among Veteran cohorts (Dobscha et al., 2009), and PTSD 
symptom severity in active duty military personnel (Engel et al., 2008; Cigrang et al., 
2011). Accordingly, we were expecting to observe higher self-reported mental health 
scores, and lower depression and PTSD symptom severity among Veterans who received 
IMH (vs. UMH care). Contrary to our expectations, however, no differences were 
observed in patient’s perceptions of mental health status, depression (baseline, last 
recorded, or PHQ-9 difference scores) or PTSD symptom severity (baseline, PCL 
difference scores) among patients comprising our two Veteran groups.  
 Particularly for depression and PTSD symptom severity, however, multiple scores 
were available for only a small number of participants. As such, results should be 
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interpreted with caution, since they may not be representative of the actual severity of 
depression and PTSD severity among all Veterans in the sample and further, may not be 
generalizable to Veterans receiving VA mental health care in general. The limited 
number of patients for whom multiple standardized assessments of symptom severity 
were available may be a result of in-depth assessments of symptom severity not being 
conducted, however, these ‘missing’ data may alternatively be a result of the provider 
having conducted but failed to document such assessments, or results of the assessments, 
in the note for that visits. However, these findings may corroborate recommendations that 
system-wide, standardized screening and in-depth assessment procedures for mental 
health diagnoses should be developed and implemented (Kearny, Wray, Dollar, & King, 
2015).  
 We did find that Veterans in our two groups differed on endorsement of some 
PTSD symptom clusters. Specifically, visit-level chart review data indicated that a 
greater proportion of Veterans receiving IMH (vs. UMH) reported experiencing 
symptoms consistent with intrusion, as well as alterations in arousal and reactivity, during 
primary care or mental health encounters with VA providers. This is relatively surprising, 
as IMH treatment is typically less intensive than specialty mental health care (Dundon, 
Dollar, Schohn, & Lantinga, 2011; Possemato, 2011), and persons with more severe 
symptoms who need more intensive treatment are usually referred out to specialty mental 
health clinics (i.e., UMH). However, it is likely the case that, since IMH treatment is 
associated with increased patient activation/engagement in care, Veterans receiving IMH 
treatment may be more open/expressive about their symptom endorsement during health 
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care encounters, thusly making it appear that they are more likely to endorse symptoms 
when in actuality they are merely talking about their symptoms more openly.  
Patient Perceptions of Patient-Centered Care Constructs Associated with the 
Receipt of Integrative Mental Health Treatment 
 IMH treatment delivery within the VA health care system is a patient-centered 
method of managing mental health concerns among Veterans, an integral facet to 
ensuring that health care is being delivered in a truly patient-centered way (Croghan, & 
Brown, 2010). Despite this, however, literature examining the relationship between 
patient-centered care outcomes and IMH treatment receipt is lacking. Since IMH is a 
patient-centered care related effort, we were expecting that patient’s perceptions of 
patient-centered care constructs would be higher among Veterans who received IMH, as 
compared to those who received UMH care.  
 Our data identified that following IMH treatment, Veterans with PTSD reported 
higher levels of patient activation (i.e., engagement in their health care) than those who 
received UMH care. These findings are concordant with the postulation that IMH 
treatment increases engagement in mental health care among Veterans with mental health 
concerns (Pomerantz, Kearney, Wray, Post, & McCarthy, 2014). Additionally, we found 
that Veterans in the IMH group reported marginally higher perceptions of the decision-
making effectiveness component of SDM, on average, than did Veterans in the UMH 
group. One of the central tenets of the effectiveness of IMH treatment delivery is that it 
reduces the stigma associated with seeking mental health care (Collins, Hewson, Munger, 
& Wade, 2010; WHO, 2008). As such, it is likely the case that stigma reduction 
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facilitates engagement in mental health care. In turn, decreased stigma and increased 
engagement in care may catalyze Veterans with PTSD to actively participate in 
conversations with their providers, thereby facilitating shared medical decision-making 
and increasing patient’s satisfaction with the medical decision-making process.    
The Relationship Between IMH Treatment and Receipt of Adequate Mental Health 
Treatment in the Context of Patient Perceptions of Patient-Centered Care 
Constructs   
The mediation analyses conducted indicate that the pathway through which IMH 
treatment may impact patient’s likelihood of receiving adequate mental health treatment 
in the year following treatment initiation is not increased patient activation or shared 
medication decision-making on their own. However, moderated mediation analyses 
descriptively indicated that for patients receiving IMH treatment, perceptions of shared 
medical decision-making (particularly the extent to which patients believe they were 
presented with all possible treatment options, were involved in making a decision about 
which treatment option/regiment was most suitable for them and were satisfied with the 
treatment plan they came up with alongside their provider) may lead to adequate 
treatment receipt for individuals who are highly engaged in their health care (e.g., 
reported high levels of patient activation), but not for patients with low levels of health 
care engagement. In fact, the impact of shared medical decision-making on the 
relationship between type of treatment received and subsequent receipt of ‘adequate’ 
mental health care was about 4 times larger in Veterans with high patient activation then 
for those with low activation. Although our results were not reliably consistent with our 
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predictions for moderated mediation, the absolute size of relationship differences might 
merit further investigation. 
 A possible mechanism for this relationship begins with the association between 
IMH and increased engagement in health care, which has been found among adults with 
mental health concerns in the general population (Bartels, Coakley, Zubritsky, et al. 
2004) as well as Veterans with mental health concerns (Pomerantz, Kearney, Wray, Post, 
& McCarthy, 2014). Further, the results of the current study indicate that receiving IMH 
care also leads to patients feeling more like their providers communicated effectively 
with them and allowed them have a say in treatment decisions, a finding that is 
corroborated with our chart review data, which suggests that patient preferences may 
have been discussed more in IMH visits compared to usual care visits. Collectively, 
increased engagement in mental health care may lead to an increased likelihood of 
patients following up with mental health care needs, as well as empowering patients to 
actively engage in conversations about treatment decision-making with their mental 
health care providers. Simultaneously, the consideration of patient preferences in mental 
health care treatment recommendations and providers engaging in shared medical 
decision-making with patients may also lead to increased patient engagement in care, and 
in turn, greater adherence to treatment regiments.  
 The lack of statistically significant findings in the moderated mediation analyses, 
despite the fact that descriptively the findings appear indicative of a relationship being 
present, may have more to do with lack of power then lack of an actual effect. In fact, the 
relatively small sample size available for these analyses would only be adequately 
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powered if a very large effect was present; given the effect sizes found in the mediation 
analyses for the present study, a sample size of over 400 individuals would be needed to 
detect a significant mediation effect (Fritz & MacKinnon, 2007). Given that the 
mediation and moderated mediation analyses in the present study were dependent on a 
sample less than 50 Veterans, a larger study may be warranted to give due diligence to 
testing these relationships.   
 The results of the mediation and moderated mediation analyses conducted for the 
present study may also shine some light on the potential reason behind some of the non-
significant findings regarding general and mental health care utilization. For instance, the 
proportion of our sample that reported high and low patient activation was relatively 
equivalent (though overall patient activation was higher in those who received IMH 
care). As activation seems to matter greatly in terms of which patients participate actively 
in mental health care treatment for PTSD, it may be the case that patient activation 
leveled out potential differences in various aspects of health care utilization between the 
IMH and UMH groups, washing out potential (hypothesized) differences. Consequently, 
the lack of differences in some facets of appropriate health care utilization (e.g., number 
of filled prescriptions for medication) may be related to the lack of observed differences 
in proxy indicators of physical health (e.g., chronic condition management indicators for 
diabetes, hypertension and hyperlipidemia). As such, future research examining the 
interplay between patient activation and health care utilization may be warranted with a 
larger cohort of individuals, to allow for adequately powered multi-way crosstab analyses 
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to examine differences among utilization variables in Veterans who have PTSD with high 
vs. low activation who receive IMH vs. UMH care.  
Limitations  
 Several limitations to the current study should be noted. Specifically, in regard to 
the data obtained via the patient-centered care survey, as with any self-reported survey 
data this information may have been influenced by response bias and/or social 
desirability bias. Further, as the instructions for the scales included in the patient-centered 
care survey did not specify that questions related to mental health care, there is no way to 
ascertain that participants were thinking about mental health care or interactions with 
mental health care providers specifically when responding to the survey questions. 
Additionally, the small sample size of the survey data coupled with a modest amount of 
survey data, as well as the large amount of missing chart review data regarding 
depression and PTSD symptom severity, limited both power and generalizability of the 
results.  
 In regard to the chart review data, the lack of notation about patient preferences in 
the notes documenting the primary care and mental health visits reviews does not 
necessarily indicate that patient preferences were not actually discussed during the visit, 
merely that they were not documented (e.g. full discussions/all details of visits may not 
be reflected in the charts). Additionally, discussion of patient preferences for treatment 
were not necessarily appropriate during all notes reviewed and included in analyses (e.g., 
primary care and/or mental health nursing encounters).  
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 Further, while the facilities designated ‘controls’ in this project may not have 
been designated PCC COIs, it is possible that elements of PCC innovations were being 
implemented at those facilities too. If control facilities knew of ongoing successful 
innovations at the COIs and were practicing programs or elements of programs as well, 
‘contamination’ of the control group may have occurred, and this may possible account 
for some of the null findings in this study as well. Finally, the retrospective and 
evaluative nature of this study, while affording the results great ecological validity, limit 
the internal validity; therefore, we cannot ascertain that any of the differences observed 
were a result of receiving IMH treatment.  
Future Directions  
 While a number of potential focus areas have been identified by this project in 
regard to future research which could be warranted and useful in the area of outcomes of 
IMH treatment delivery, one overall recommendation is that a prospective study 
following new Veteran patients with PTSD receiving IMH and UMH care, from 
treatment initiation for at least one year may be warranted. This would allow for 
systematic and controlled collection of baseline data, along with data at multiple points of 
follow-up data, to identify differences in outcomes of interest. Additionally, a greater 
amount of primary data collection would be useful to truly understand the impact of IMH 
treatment delivery on patient’s perceived experiences with their VA mental health care. 
Specifically, in-depth interviews with Veteran patients and providers, as well as a survey 
focused entirely on perceptions of patient-centered care as it related to mental health care, 
would provide rich detail about how the IMH mechanism affects the patient experience.   
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Conclusions/Implications 
 Conclusions based on the present results are at best tentative and showed few 
reliable advantages of IMH over UMH.  However, combining behavioral health care with 
traditional primary care through an integrative mental health treatment model may be 
most effective in increasing health care engagement, shared decision-making, and 
discussion of patient preferences for mental health care among Veterans with PTSD. As 
such, these treatment efforts may be effective in increasing the number of Veterans who 
receive appropriate, needed health care, as well as improving mental health care-related 
satisfaction. However, data indicate that some targeted improvement efforts geared 
toward educating providers about the importance of discussing and considering patient’s 
preference for treatment, as well as implementing systematic collection of standardized 
measures of symptom severity for common mental health concerns among Veterans 
receiving VA health care, may be warranted. Collectively, integrating mental health care 
providers into the primary care setting may be a good strategy for encouraging Veterans 
with PTSD to seek out and stay the course of the treatment they need.  
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VARIABLES TABLE 
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Variable Source Specifications 
Demographics and Veteran Characteristics 
Gender VA Administrative Data Male; Female 
Age VA Administrative Data Veteran’s age (continuous) 
Race VA Administrative Data White; Black; Other 
Ethnicity  VA Administrative Data Hispanic/Latino; Non-
Hispanic/Latino 
Marital Status VA Administrative Data Married; Not Married 
Service Connection VA Administrative Data Service Connected Disability 
Percentage: 0%, 1-49%, 50-
100% (highest recorded) 
Chronic Conditions 
Heart disease VA Administrative Data ICD-9 codes: 402, 404, 410-
429 
Cancer VA Administrative Data ICD-9 codes: 140-208, 238.6 
Chronic lower respiratory 
disease 
VA Administrative Data ICD-9 codes: 490-496 
*includes bronchitis, 
emphysema, asthma, 
bronchiectasis, extrinsic 
allergic alveolitis, chronic 
airway obstruction NOS 
Stroke  VA Administrative Data ICD-9 codes: 430-438 
Diabetes VA Administrative Data ICD-9 codes: 250 
Multimorbidity VA Administrative Data 2 or more of the 2 chronic 
conditions examined 
Number of chronic 
conditions 
VA Administrative Data Total number of chronic 
conditions (continuous) 
Comorbid Mental Health Diagnoses 
Adjustment disorders VA Administrative Data ICD-9 codes: 309.0, 309.1, 
309.2, 309.21, 309.22, 309.23, 
309.24, 309.29, 309.29, 309.3, 
309.4, 309.82, 309.83, 309.89, 
309.9 
Anxiety disorders VA Administrative Data ICD-9 codes: 293.84, 300.00, 
300.01, 300.02, 300.09, 
300.10, 300.20, 300.21. 
300.22, 300.29, 300.3, 300.5, 
300.89, 300.9, 308.0, 308.1, 
308.2, 308.3, 308.4, 308.9, 
313.0, 313.1, 313.2, 313.21, 
313.22, 313.3, 313.82, 313.83 
PTSD VA Administrative Data ICD-9 codes: 309.81 
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Impulse control disorders 
(including pathological 
gambling) 
VA Administrative Data ICD-9 codes: 312.30, 312.31, 
312.32, 312.33, 312.34, 
412.35, 312.39 
Bipolar disorders VA Administrative Data ICD-9 codes: 296.00, 296.01, 
296.02, 296.03, 296.04, 
296.05, 296.06, 296.10, 
296.11, 296.12, 296.13, 
296.14, 296.15, 296.16, 
296.40, 296.41 296.42, 296.43, 
296.44, 296.45, 296.46, 
296.50, 296.51, 296.52, 
296.53, 296.54, 296.55, 
296.56, 296.60, 296.61, 
296.62, 296.63, 296.64, 
296.65, 296.66, 296.67, 
296.80, 296.81, 296.82, 
296.89, 296.90, 296.99 
Depressive disorders VA Administrative Data ICD-9 codes: 293.83, 296.20, 
296.21, 296.22, 296.23, 
296.24, 296.25, 296.26, 
296.30, 296.31, 296.31, 
296.22, 296.34, 296.35, 
296.36, 300.4, 311 
Personality disorders VA Administrative Data ICD-9 codes: 301.0, 301.01, 
301.11, 301.12, 301.13, 
301.20, 301.21, 301.22, 301.3, 
301.4, 301.50, 301.51, 301.59, 
301.6, 301.7, 301.81, 301.82, 
301.83, 301.84, 301.89, 301.9 
Schizophrenia and other 
psychotic disorders 
VA Administrative Data ICD-9 codes: 293.81, 293.82, 
295.00, 295.01, 295.02, 
295.03, 295.04, 295.05, 
295.10, 295.11, 295.12, 
295.13, 295.14, 295.15, 
295.20, 295.21, 295.22, 
295.23, 295.24, 295.25, 
295.30, 295.31, 295.32, 
295.33, 295.34, 295.35, 
295.40, 295.41, 295.42, 
295.43, 295.44, 295.45, 
295.50, 295.51, 295.52, 
295.53, 295.54, 295.55, 
295.60, 295.61, 295.62, 
295.63, 295.64, 295.65, 
  
111 
295.70, 295.71, 295.72, 
295.73, 295.74, 295.75, 
295.80, 295.81, 295.82, 
295.83, 295.84, 295.85, 
295.90, 295.91, 295.92, 
295.93, 295.94, 295.95, 297.0, 
297.1, 297.2, 297.3, 297.8, 
297.9, 298.0, 298.1, 298.2, 
298.3, 298.4, 298.8, 298.9 
Substance use disorders VA Administrative Data ICD-9 codes: 
Alcohol: 291.0, 291.2, 291.2, 
291.3, 291.4, 291.5, 291.8, 
291.81. 291.82, 291.89, 291.9, 
303.00, 303.01, 303.02, 
303.03, 303.90, 303.91, 
303.92, 303.93, 305.00, 
305.01, 305.02, 305.03, 980.0 
Substance: 292.0, 292.11, 
292.12, 292.2, 292.81, 292.82, 
292.83, 292.84, 292.85, 
292.89, 292.9, 304.00, 304.01, 
304.02, 304.03, 304.10, 
304.11, 304.12, 304.13, 
304.20, 304.21, 304.22, 
304.23, 304.30, 304.31, 
304.32, 304.33, 304.40, 
304.41, 304.42, 304.43, 
304.50, 304.51, 304.52, 
304.52, 304.60, 304.61, 
304.62, 304.63, 304.70, 
304.71, 304.72, 304.73, 
304.80, 304.81, 304.82, 
304.83, 304.90, 304.91, 
304.92, 304.93, 305.20, 
305.21, 305.22, 305.23, 
305.30, 305.31, 305.32, 
305.33, 305.40, 305.41, 
305.42, 305.43, 305.50, 
305.51, 305.52, 305.53, 
305.60, 305.61, 305.62, 
305.63, 305.70, 305.71, 
305.72, 305.73, 305.80, 
305.81, 305.82, 305.83, 
305.90, 305.91, 305.92, 
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305.93, 648.30, 648.31, 
648.32, 648.33, 648.34, 
655.50, 655.51, 655.53, 
965.00, 965.01, 965.02, 965.09  
Suicide and intentional self-
injury 
VA Administrative Data ICD-9 codes: E9500, E9501, 
E9502, E9503, E9504, E9505, 
E9506, E9507, E9508, E9509, 
E9510, E9511, E9518, E9520, 
E9521, E9528, E9529, E9530, 
E9531, E9538, E9539, E954, 
E955, E9551, E9552, E9553, 
E9554, E9555, E9556, E9557, 
E9559, E956, E9570, E9571, 
E9572, E9579, E958, E9581, 
E9582, E9583, E9584, E9585, 
E9586, E9587, E9588, E9589, 
E959, V6284 
Military sexual trauma VA Administrative Data Positive answer provided to 
VA Military Sexual Trauma 
screener 
Mental Health Services Utilization 
Adequate mental health 
care utilization 
VA Administrative Data 9 or more mental health 
treatment visits within 12 
months of the patient’s index 
Outpatient visits related to 
mental health services  
VA Administrative Data Outpatient visits with primary 
or secondary mental health 
clinic stop 
Prescription psychotropic 
medication fills  
VA Administrative Data Antidepressants (CN600, 
CN601, CN602, CN609); 
Antipsychotics (CN700, 
CN701, CN709); Anxiolytics 
(CN300, CN301, CN302, 
CN309); Stimulants (CN800, 
CN801, CN802, CN809); 
Lithium (CN750) 
Visits specifically 
associated with mental 
health conditions 
VA Administrative Data A visit will be considered to be 
for a particular condition if the 
primary diagnosis code for that 
visit was an ICD-9 code for 
that condition 
General Health Services Utilization 
Inpatient visits  VA Administrative Data Hospitalizations 
Average length of stay  VA Administrative Data Length of hospitalizations, if 
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any 
Outpatient visits (general)  VA Administrative Data  
Primary care visits  VA Administrative Data  
Emergency department 
visits  
VA Administrative Data  
Prescription medication fills 
(general) 
VA Administrative Data  
Physical Health (Clinical Indicators) 
blood pressure 
(hypertension) 
VA Administrative Data Number of visits associated 
with poor condition 
management: diastolic blood 
pressure ≥ 90 and systolic 
blood pressure ≥ 140 
Hemoglobin A1c (diabetes)  VA Administrative Data Number of visits associated 
with poor condition 
management: HbA1c ≥9% 
LDL (Hyperlipidemia) VA Administrative Data Number of visits associated 
with poor condition 
management: LDL ≥ 130 
Mental Health Comorbidities  
Pain Severity Chart Review Data 0-10 rating scale of current 
pain level 
Depression Severity Chart Review Data PHQ-9 score(s) 
PTSD Symptoms 
Symptom Endorsement Chart Review Data PTSD symptoms that the 
patient is experiencing; 
symptom clusters and 
individual symptoms will be 
recorded 
Symptom Severity Chart Review Data PCL Score(s) 
Provider Recommendations for Treatment and Patient Preferences 
Provider’s treatment 
recommendations 
Chart Review Data Psychotherapy; Pharmacology; 
CAM 
Patient preferences for 
treatment 
Chart Review Data Based on a comprehensive 
assessment of the content of 
progress notes across the 
course of treatment 
Sub-Set Analysis of Patients for Whom CEPEP Survey Data Are Available 
Self-Reported Health Status 
Physical Health Summary CEPEP Survey
1 
VR-12 PCS Score 
Mental Health Summary CEPEP Survey
1
 VR-12 MCS Score 
Patient Perceptions of Patient-Centered Care Constructs 
Satisfaction with health care CEPEP Survey
1
 Global Practice Experience 
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facility measure (GPE) score 
Perceptions of provider’s 
empathy and patient-
provider communication 
CEPEP Survey
1
 Consultation and Relational 
Empathy (CARE) score 
Engagement in Health Care CEPEP Survey
1
 Patient Activation Measure 
(PAM) score 
Family involvement in care, 
respect for choices, and 
support 
CEPEP Survey
1
 Press-Ganey Question score 
Perceptions of chronic 
illness care 
CEPEP Survey
1
 Patient Assessment of Chronic 
Illness Care (PACIC) score 
Shared decision-making CEPEP Survey
1
 Combined Outcome Measure 
for Risk Communication and 
Treatment Decision Making 
Effectiveness (COMRADE) 
score 
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APPENDIX B 
 
CHART REVIEW FORM 
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1. Patient problem list (Verbatim): 
 
 
2. Index visit coded in the administrative data as:   
☐ Integrative Mental Health (1)  
☐ Control (Mental Health ‘Usual Care’) (0) 
 2a. If Control, what mental health clinic was the visit associated with? 
 
PSYCHOLOGICAL COMORBIDITIES 
 
3. Is there documentation of a validated PTSD assessment for this patient? 
☐ Yes (1)   ☐ No (0)  
 
 3a. If yes, which assessment was it:  
 ☐ PTSD Checklist (PCL) 
 ☐ Clinician Administered PTSD Scale (CAPS) 
 ☐ PTSD Symptom Scale – Interview (PSSI) 
 ☐ Other [*Specify:_____________] 
 
 3b. Score and provider notes regarding assessment (if any) and date the assessment was administered 
(verbatim): 
 
 
4. Is there documentation of an assessment of pain? 
☐ Yes (1)   ☐ No (0)  
 
 4a. If yes, copy pain score/content and date (verbatim): 
 
 
5. Is there documentation of an assessment/diagnostic interview for depression? 
☐ Yes (1)   ☐ No (0)  
 
5a. If yes, indicate name of assessment and score, and date (verbatim): 
 
 
6. Is there documentation of an assessment/diagnostic interview for anxiety? 
☐ Yes (1)   ☐ No (0)  
 
6a. If yes, indicate name of assessment and score, and date (verbatim): 
 
 
7. Is there any documentation related to substance abuse? 
☐ Yes (1)   ☐ No (0)  
 
7a. If yes, indicate details (verbatim): 
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Appendix C. Chart Review Form 
 
Integrative Mental Health in PTSD Chart Review Tool: 
PTSD Symptoms – Frequency, Severity, Treatment Recommendations 
 
2. Date of Visit:  __ __\__ __\__ __  : 2. Date of note:  __ __\__ __\__ __        
 
3. Visit and provider type: ________ / 4. Standard title: ________   5.Local title: _______  
 
6.  Does the note appear to include standard text (i.e. copy and pasted or repeated in other notes?) ☐ Yes 
(1)   ☐ No (0) 
 
SYMPTOMS AT VISIT (check all that apply) 
 
7. Did the note mention overall PTSD symptoms, in general:  
 ☐  Yes  
 ☐  No  
  
 7a. Did the note mention a change in overall PTSD symptoms, in general?  
 ☐  Yes (From: ______________________ ) [Timeframe of change in symptoms, if mentioned] 
 ☐  No  
 
 7d. Provider notes regarding overall PTSD symptoms, if any (verbatim): 
   
 
8. Criterion B: Intrusion Symptoms – traumatic event is persistently re-experienced in the following 
way(s)  
 ☐  Symptom(s) present [go to question 8a] 
 ☐  Not Mentioned [go to question 9] 
 ☐  No symptoms [chart specified that no symptoms were present at this visit – go to question 9] 
 
8a. Check all Intrusion Symptoms that are present (if any):       
   
☐ Recurrent, involuntary, and intrusive memories  
☐ Traumatic nightmares 
☐ Dissociative reactions (e.g., flashbacks) which may occur on a continuum from brief episodes to 
complete loss of consciousness 
☐ Intense or prolonged distress after exposure to traumatic reminders 
☐ Marked physiologic reactivity after exposure to trauma-related stimuli 
☐ Other: ____________________________________________________________________ 
 
 8b. Was a change in Intrusion Symptoms mentioned?  
 ☐  Yes (From: ______________________ ) [Timeframe of change in symptoms, if mentioned] 
 ☐  No  
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8c. Provider notes regarding intrusion symptoms, if any (verbatim): 
   
  
9. Criterion C: Avoidance - Persistent effortful avoidance of distressing trauma-related stimuli after the 
event  
 ☐  Symptom(s) present [go to question 9a] 
 ☐  Not Mentioned [go to question 10] 
 ☐  No symptoms [chart specified that no symptoms were present at this visit – go to question 10] 
 
9a. Check all Avoidance Symptoms that are present (if any):  
☐ Trauma-related thoughts or feelings 
☐ Trauma-related external reminders (e.g., people, places, conversations, activities, objects, or situations) 
☐ Other: ____________________________________________________________________ 
 
 9b. Was a change in Avoidance Symptoms mentioned?  
 ☐  Yes (From: ______________________ ) [Timeframe of change in symptoms, if mentioned] 
 ☐  No  
 
9c. Provider notes regarding avoidance symptoms, if any (verbatim): 
   
 
10. Criterion D: Negative Alterations in Cognitions and Mood - Negative alterations in cognitions and 
mood that began or worsened  after the traumatic event   
 ☐  Symptom(s) present [go to question 10a] 
 ☐  Not Mentioned [go to question 11] 
 ☐  No symptoms [chart specified that no symptoms were present at this visit – go to question 11] 
 
10a. Check all Symptoms of Negative Alterations in Cognitions and Mood that are present (if any):  
☐ Inability to recall key features of the traumatic event (usually dissociative amnesia; not due to head 
injury, alcohol or drugs) 
☐ Persistent (and often distorted) negative beliefs and expectations about oneself or the world (e.g., "I am 
bad," "The world is completely dangerous.") 
☐ Persistent distorted blame of self or others for causing the traumatic event or for resulting consequences 
☐ Persistent negative trauma-related emotions (e.g., fear, horror, anger, guilt or shame) 
☐ Markedly diminished interest in (pre-traumatic) significant activities 
☐ Feeling alienated from others (e.g., detachment or estrangement) 
☐ Constricted affect: persistent inability to experience positive emotions 
☐ Other: 
_______________________________________________________________________________ 
 
10b. Was a change in Symptoms of Negative Alterations in Cognitions and Mood mentioned?  
 ☐  Yes (From: ________________ ) [Timeframe of change in symptoms, if mentioned] 
 ☐  No  
 
10c. Provider notes regarding symptoms of Negative Alterations in Cognitions and Mood, if any 
(verbatim): 
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11. Criterion E: Alterations in Arousal and Reactivity - Trauma-related alterations in arousal and 
reactivity that began or worsened after the traumatic event  
 ☐  Symptom(s) present [go to question 11a] 
 ☐  Not Mentioned [go to question 12] 
 ☐  No symptoms [chart specified that no symptoms were present at this visit – go to question 12] 
 
11a. Check all Alterations in Arousal and Reactivity Symptoms that are present (if any):  
☐ Irritable or aggressive behavior  
☐ Self-destructive or reckless behavior 
☐ Hypervigilance 
☐ Exaggerated startle response 
☐ Problems in concentration 
☐ Sleep disturbance 
☐ Other: 
________________________________________________________________________________ 
 
 11b. Was a change in Symptoms of Alterations in Arousal and Reactivity mentioned?  
 ☐  Yes (From: ______________ ) [Timeframe of change in symptoms, if mentioned]   
☐ No  
 
11c. Provider notes regarding symptoms of Alterations in Arousal and Reactivity, if any (verbatim): 
   
 
12. Functional significance (i.e., significant symptom-related distress or functional impairment (e.g., 
social, occupational)) mentioned (verbatim): 
   
 ☐  Not Mentioned 
 ☐  No symptoms                 
 
13. Depersonalization (i.e., experience of being an outside observer of or detached from oneself (e.g., 
feeling as if "this is not happening to me" or one were in a dream) mentioned (verbatim): 
   
 ☐  Not Mentioned 
 ☐  No symptoms                 
 
14. Derealization (i.e., experience of unreality, distance, or distortion (e.g., "things are not real")) 
mentioned (verbatim): 
 
 ☐  Not Mentioned 
 ☐  No symptoms                 
 
15. Did the patient display suicidal ideation?  
☐ Yes (1)   ☐ No (0)  ☐ Not Mentioned 
 
TREATMENT RECOMMENDATIONS 
 
16. Did the note include any documentation related to recommendation(s) for treatment? 
  
120 
☐ Yes (1)   ☐ No (0)  
 
 16a. If yes, was the recommendation for: check all that apply 
 ☐ Psychotherapy 
 ☐ Pharmacology 
 ☐ CAM (i.e., acupuncture, yoga, MBSR, etc.) [*Specify modality:_________] 
  
 16b. Provider recommendation(s) (verbatim): 
 
 
17. Did the visit result in any consult(s) or referrals for future treatment? 
☐ Yes (1)   ☐ No (0)  
 
 17a. If yes, was the consult for: check all that apply 
 ☐ Psychotherapy 
 ☐ Pharmacology 
 ☐ CAM (i.e., acupuncture, yoga, MBSR, etc.) [*Specify modality:_________] 
 
 17b. Provider consult(s) (verbatim): 
 
 
18. Did the note include any documentation of current treatment? 
☐ Yes (1)   ☐ No (0)  
18a. Provider’s details about current treatment (verbatim): 
 
 
19. Communication about the patient’s preferences for treatment occurred. 
☐ Yes (1)   ☐ No (0) 
 
19a. Details about provider’s probe and patient’s treatment preferences (verbatim): 
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APPENDIX C 
PTSD CHECKLIST (PCL) - MILITARY VERSION 
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Below is a list of problems and complaints that veterans sometimes have in response to a 
stressful military experience. Please read each one carefully, put an “X” in the box. 
  
Not 
at all 
A 
little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  
Repeated, disturbing memories, thoughts, or images of a 
stressful military experience?       
2.  
Repeated, disturbing dreams of a stressful military 
experience?       
3.  
Suddenly acting or feeling as if a stressful military 
experience were happening again (as if you were reliving 
it)?  
     
4.  
Feeling very upset when something reminded you of a 
stressful military experience?       
5.  
Having physical reactions (e.g., heart pounding, trouble 
breathing, or sweating) when something reminded you of a 
stressful military experience?  
     
6.  
Avoid thinking about or talking about a stressful military 
experience or avoid having feelings related to it?       
7.  
Avoid activities or talking about a stressful military 
experience or avoid having feelings related to it?       
8.  
Trouble remembering important parts of a stressful military 
experience?       
9.  Loss of interest in things that you used to enjoy?  
     
10.  Feeling distant or cut off from other people?  
     
11.  
Feeling emotionally numb or being unable to have loving 
feelings for those close to you?       
12.  Feeling as if your future will somehow be cut short?  
     
13.  Trouble falling or staying asleep?  
     
14.  Feeling irritable or having angry outbursts?  
     
15.  Having difficulty concentrating?  
     
16.  Being “super alert” or watchful on guard?  
     
17.  Feeling jumpy or easily startled?  
     
Has anyone indicated that you’ve changed since the stressful military experience?  
Yes __ No__  
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APPENDIX D 
CEPEP SURVEY WITH SCALES LABELED 
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PATIENT-CENTERED CARE SURVEY 
VETERAN PATIENT DEMOGRAPHICS AND CHARACTERISTICS ASSESSMENT (PDCA) 
Please answer all questions.  Your answers will be kept confidential. 
(1) Have you seen a doctor or been in the hospital during the past 6 months (from about August 2012 until now – early 2013)?  
   Yes, a VA doctor or VA hospital  (Please check all that apply) 
   Yes, a non-VA doctor or non-VA hospital 
   No, I have not seen a doctor or been in the hospital  
(2) What is your gender?    Male    Female  
(3) What is your age? ________  years 
(4) Are you Hispanic or Latino?    No   Yes   Don’t Know/Not Sure  
(5) Which one of the following would you say best represents your race?  (Please check one) 
    White   Native Hawaiian/Other Pacific Islander 
    Black or African American    American Indian or Alaska Native      
    Asian   Other (specify) _____________________________________________ 
    Don’t Know/Not Sure  
(6) How much school have you completed?   (Please check one) 
    Did not complete elementary school     High school graduate (grade 12 or GED) 
    Elementary (grades 1 through 8)     Some college or technical school    
    Some high school (grades 9 through 11)   College graduate (4 years or more) 
 (7) How would you describe your current relationship status? (Please check one) 
    Married     Member of an unmarried couple 
    Separated/ Divorced   Widowed 
    Never married 
(8) Which of the following most closely describes your usual living arrangements? (Please check one) 
    Live alone 
    Live with family, friend, spouse/other       
    Live with formal (hired/paid) caregiver   
    Other ____________________________________________ (please specify) 
(9)  On average, what is the distance between your home and the VA facility from which you 
       most often receive your care? Please enter an answer and circle blocks or miles.  
    _________  blocks / miles 
(10) On average, about how long does it take you to get from your home to the VA facility  
        from which you most often receive your care ? 
    ___________ minutes 
(11) About how often do you typically access the Internet? 
    Daily 
    Weekly        Please proceed to #12 and #13 
    Monthly 
    Less than once per month 
    I do not use/access the Internet (if selected this option, please skip to #14) 
(12) Where do you most often access/use the Internet? (Please check one) 
 Home   Family/Friend’s home  Work  VA 
 Public place (e.g., library, community center)  Other, specify: ________________ 
(13) What do you use the Internet for? (Please check all that apply) 
 Email  News  Entertainment 
 Health information  Social networking (e.g., Facebook)  Other: ____________________ 
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THE GLOBAL PRACTICE EXPERIENCE MEASURE 
 (14)  Please indicate the extent to which you agree or disagree with the following statements: 
At my VA health care practice … 
Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
I receive exactly the care I want and need when and how I 
want and need it. 
    
I am delighted with this practice. 
    
(15)  Have you ever been asked by your VA facility to serve on a VA quality improvement committee, advisory 
        group, or decision-making team to represent the views of Veteran patients to improve care delivery?   
  No   
  Yes  (please specify) _______________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
(16)  Have you ever been asked (survey, interview) by your VA about your preferences for the design structure, 
         architecture, layout, etc. to enhance patient/family comfort, privacy, and/or convenience? 
  No   
  Yes  (please specify) _______________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
(17)  We are interested in knowing more about your general experience as a VA patient, in your own words. 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________
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THE CONSULTATION AND RELATIONAL EMPATHY MEASURE (CARE) 
Now, we would like you to please rate the following statements about your recent visit/clinical encounter to the VA. 
Please   check one box for each statement and answer every statement.
How was your VA health care provider at . . . Poor Fair Good Very 
Good 
Excellent 
Does  
Not 
Apply 
1. Making you feel at ease . . . . . .
(being friendly and warm towards you,  
treating you with respect; not cold or abrupt) 
     
2. Letting you tell your “story” . . . . . .
(giving you time to fully describe your illness in  
your own words; not interrupting or diverting you) 
     
3. Really listening . . . . . .
(paying close attention to what you were saying; not 
 looking at the notes or computer as you were talking) 
     
4. Being interested in you as a whole person . . .
(asking/knowing relevant details about your life,  
your situation; not treating you as “just a number”) 
     
5. Fully understanding your concerns . . . . . .
(communicating that he/she had accurately understood 
your concerns; not overlooking or dismissing anything) 
     
6. Showing care and compassion . . . . .
(seeming genuinely concerned, connecting with you on 
a human level; not being indifferent or “detached”) 
     
7. Being positive . . . . . .
(having a positive approach and a positive attitude;  
being honest but not negative about your problems) 
     
8. Explaining things clearly. . . . . . . .
(fully answering your questions, explaining clearly, 
 giving you adequate information; not being vague) 
     
9. Helping you take control . . . . . .
(exploring with you what you can do to improve your  
health yourself; encouraging rather than “lecturing” you) 
     
10. Making a plan of action with you . . .
(discussing the options, involving you in decisions as 
much as you want to be involved; not ignoring your 
views) 
     
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PATIENT ACTIVATION MEASURE (PAM) 
Below are some statements that people sometimes make when they talk about their health.   Please indicate how much you agree or 
disagree with each statement as it applies to you personally by circling your answer.  Your answers should be what is true for you and not 
just what you think the doctor wants you to say. 
1. When all is said and done, I am the person who is responsible for taking 
care of my health.
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
2. Taking an active role in my own health care is the most important thing 
that affects my health.
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
3. I am confident I can help prevent or reduce problems associated with my 
health.
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
4. I know what each of my prescribed medications do. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
5. I am confident that I can tell whether I need to go to the doctor or whether I 
can take care of a health problem myself. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
6. I am confident that I can tell a doctor concerns I have even when he or she 
does not ask. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
7. I am confident that I can follow through on medical treatments I may need 
to do at home. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
8. I understand my health problems and what causes them. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
9. I know what treatments are available for my health problems. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
10. I have been able to maintain (keep up with) lifestyle changes, like eating 
right or exercising.
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
11. I know how to prevent problems with my health. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
12. I am confident I can figure out solutions when new problems arise with my 
health.
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
13. I am confident that I can maintain lifestyle changes, like eating right and 
exercising, even during times of stress. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
PRESS-GANEY PATIENT SATISFACTION SURVEY 
Please select one answer for each (items a-f). very 
poor poor fair good 
very 
good 
a. Degree to which you and your family were able to participate in decisions
about your care
    
b. How well staff explained their roles in your care
    
c. Degree to which the staff supported your family throughout your healthcare 
experience
    
d. Degree to which your choices were respected to have family members/friends 
with you during your care
    
e. Degree to which staff respected your family’s cultural and spiritual needs     
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PATIENT ASSESSMENT OF CHRONIC ILLNESS CARE (PACIC) 
 Staying healthy can be difficult when you have a chronic condition. Now, we would like to learn about the type of help with your 
condition you get from your health care team. This might include your regular doctor, nurse, or physician’s assistant who treats 
your illness.  
None 
of the 
Time 
A Little 
of the 
Time 
Some 
of the 
Time 
Most 
of the 
Time 
Always 
1. Asked for my ideas when we made a treatment plan.
1 2 3 4 5
2. Given choices about treatment to think about.
1 2 3 4 5
3. Asked to talk about any problems with my medicines or their effects.
1 2 3 4 5
4. Given a written list of things I should do to improve my health.
1 2 3 4 5
5. Satisfied that my care was well organized.
1 2 3 4 5
6. Shown how what I did to take care of myself influenced my condition.
1 2 3 4 5
7. Asked to talk about my goals in caring for my condition.
1 2 3 4 5
8. Helped to set specific goals to improve my eating or exercise.
1 2 3 4 5
9. Given a copy of my treatment plan.
1 2 3 4 5
10. Encouraged to go to a specific group or class to help me cope with
my chronic condition.
1 2 3 4 5
11. Asked questions, either directly or on a survey, about my health
habits.
1 2 3 4 5
12. Sure that my doctor or nurse thought about my values, beliefs, and
traditions when they recommended treatments to me.
1 2 3 4 5
13. Helped to make a treatment plan that I could carry out in my daily life.
1 2 3 4 5
14. Helped to plan ahead so I could take care of my condition even in
hard times.
1 2 3 4 5
15. Asked how my chronic condition affects my life.
1 2 3 4 5
16. Contacted after a visit to see how things were going.
1 2 3 4 5
17. Encouraged to attend programs in the community that could help me.
1 2 3 4 5
18. Referred to a dietician, health educator, or counselor.
1 2 3 4 5
19. Told how my visits with other types of doctors, like an eye doctor or 
other specialist, helped my treatment.
1 2 3 4 5
20. Asked how my visits with other doctors were going.
1 2 3 4 5
Over the past 6 months, when I received care for my chronic conditions, I was: 
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This questionnaire asks for your views about your health. This information will help keep track of how you feel 
and how well you are able to do your usual activities. Answer every question by marking the answer as indicated. 
If you are unsure how to answer a question, please give the best answer you can. Please select only one answer 
for each question.   
Excellent Very Good Good Fair Poor 
1. In general, would you say your health is:     
2. The following questions are about activities you might do during
a typical day. Does your health now limit you in these activities? 
If so, how much? 
     ACTIVITIES 
Yes, limited 
a lot 
Yes, limited 
a little 
No, 
not limited 
at all 
a. Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf. .
  
b. Climbing several flights of stairs. . . . . . . . . . . ..   
3. During the past 4 weeks, have you had any of the
following problems with your work or other regular daily activities 
as a result of your physical health? 
No, 
none  
of the 
time 
Yes, 
a little 
of the 
time 
Yes, 
some 
of the 
time 
Yes, 
most  
of the 
time 
Yes, 
all of 
the 
time 
a. Accomplished less than you would like. . . . . . . . . .     
b. Were limited in the kind of work or other activities. .     
4. During the past 4 weeks, have you had any of the following
problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or 
anxious)? 
No, 
none  
of the 
time 
Yes, 
a little 
of the 
time 
Yes, 
some 
of the 
time 
Yes, 
most  
of the 
time 
Yes, 
all of 
the 
time 
a. Accomplished less than you would like. . . . . . . . . . .     
b. Didn’t do work or other activities as carefully as usual     
5. During the past 4 weeks, how much did pain interfere with
your normal work (including both work outside the home and 
housework)? 
Not at all 

A little bit 

Moderately 

Quite a bit 

Extremel
y 

These questions are about how you feel and how things have been 
with you during the past 4 weeks. For each question, please give 
the one answer that comes closest to the way you have been 
feeling.  
6. How much of the time during the past 4 weeks:
All 
of the 
time 
Most 
of the 
time 
A good 
bit of 
the time 
Some 
of the 
time 
A little 
of the 
time 
None 
of the 
time 
a. Have you felt calm and peaceful? . . . . . . . . . . . . .      
b. Did you have a lot of energy? . . . . . . . . . . . . . . . . .      
c. Have you felt downhearted and blue? . . . . . . . . . .      
7. During the past 4 weeks, how much of the time has your 
physical health or emotional problems interfered with your 
social activities (like visiting with friends, relatives, etc.)? 
All of 
the time 

Most of 
the time 

Some of 
the time 

A little of 
the time 

None of 
the time 

Now, we’d like to ask you some questions about how your health 
may have changed.  
Much better 
Slightly 
better 
About the 
same 
Slightly 
worse 
Much 
worse 
8. Compared to one year ago, how would you rate your physical
health in general now? 
    
9. Compared to one year ago, how would you rate your 
emotional problems (such as feeling anxious, depressed or 
irritable) now? 
    
VR-12 
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THE COMBINED OUTCOME MEASURE FOR RISK COMMUNICATION AND TREATMENT DECISION 
MAKING EFFECTIVENESS (COMRADE) 
Please respond to the following statements by circling the number on the scale (1 to 5) that best agrees with your view.  If 
you are not completely sure about an answer please circle the number which represents your best guess.   An example of 
how to answer a question is shown here: 
I have been to the doctor often in the last year Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
Here we refer often to “treatments” and “choices about treatment”.  One of these choices may be not to take treatment, or it may be 
that the decision was left until another time.  Whichever plan was made, please still answer all questions. 
1. The doctor made me aware of the different treatments available Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
2. The doctor gave me the chance to express my opinions about the
different treatments available Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
3. The doctor gave me the chance to ask for as much information as I
needed about the different treatment choices available Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
4.The doctor gave me enough information about the treatment choices 
available 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
5. The doctor gave enough explanation of the information about the
treatment choices 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
6. The information given to me was easy to understand Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
7. I know the advantages of treatment or not having treatment Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
8. I know the disadvantages of treatment or not having treatment Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
9. The doctor gave me a chance to decide which treatment I thought was
best for me 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
10. The doctor gave me a chance to be involved in the decisions during
the consultation 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
 131 
11. Overall I am satisfied with the information I was given Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
12. My doctor and I agreed about which treatment (or no treatment) was
best for me 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
13. I can easily discuss my condition again with my doctor Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
14. I am satisfied with the way in which the decision was made in the
consultation 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
15. I am sure that the decision made was the right one for me personally Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
16. I am satisfied that I am adequately informed about the issues
important to the decision 
Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
17. It’s clear which choice is best for me Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
18. I’m aware of the treatment choices I have Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
19. I feel an informed choice has been made Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
20. The decision shows what is most important for me Strongly 
disagree 
Strongly 
agree 
1 2 3 4 5 
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